<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v3.0 20080202//EN" "archivearticle3.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.0 20040830//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.0?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS One</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group><journal-title>PLoS ONE</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">09-PONE-RA-14525R1</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0008899</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline"><subject>Immunology/Immune Response</subject><subject>Immunology/Leukocyte Activation</subject><subject>Immunology/Leukocyte Development</subject><subject>Immunology/Leukocyte Signaling and Gene Expression</subject></subj-group></article-categories><title-group><article-title>Roles of the Src Tyrosine Kinases Lck and Fyn in Regulating &#x003b3;&#x003b4;TCR Signal Strength</article-title><alt-title alt-title-type="running-head">Lck, Fyn and &#x003b3;&#x003b4;TCR Signaling</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Laird</surname><given-names>Renee M.</given-names></name><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Hayes</surname><given-names>Sandra M.</given-names></name><xref ref-type="aff" rid="aff1"/><xref ref-type="corresp" rid="cor1"><sup>&#x0002a;</sup></xref></contrib></contrib-group><aff id="aff1"><addr-line>Department of Microbiology and Immunology, SUNY Upstate Medical University, Syracuse, New York, United States of America</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Alberola-Ila</surname><given-names>Jose</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1">Oklahoma Medical Research Foundation, United States of America</aff><author-notes><corresp id="cor1">&#x0002a; E-mail: <email>HayesSa@upstate.edu</email></corresp><fn fn-type="con"><p>Conceived and designed the experiments: RML SMH. Performed the experiments: RML SMH. Analyzed the data: RML SMH. Wrote the paper: RML SMH.</p></fn></author-notes><pub-date pub-type="collection"><year>2010</year></pub-date><pub-date pub-type="epub"><day>26</day><month>1</month><year>2010</year></pub-date><volume>5</volume><issue>1</issue><elocation-id>e8899</elocation-id><history><date date-type="received"><day>27</day><month>11</month><year>2009</year></date><date date-type="accepted"><day>6</day><month>1</month><year>2010</year></date></history><permissions><copyright-statement>Laird, Hayes. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</copyright-statement></permissions><abstract><p>Lck and Fyn, members of the Src family of tyrosine kinases, are key components of the &#x003b1;&#x003b2;TCR-coupled signaling pathway. While it is generally accepted that both Lck and Fyn positively regulate signal transduction by the &#x003b1;&#x003b2;TCR, recent studies have shown that Lck and Fyn have distinct functions in this signaling pathway, with Lck being a positive regulator and Fyn being a negative regulator of &#x003b1;&#x003b2;TCR signal transduction. To determine whether Lck and Fyn also differentially regulate &#x003b3;&#x003b4;TCR signal transduction, we analyzed &#x003b3;&#x003b4; T cell development and function in mice with reduced Lck or Fyn expression levels. We found that reducing Lck or Fyn levels altered the strength of the &#x003b3;&#x003b4;TCR signaling response, with low levels of Lck weakening &#x003b3;&#x003b4;TCR signal strength and low levels of Fyn augmenting &#x003b3;&#x003b4;TCR signal strength. These alterations in &#x003b3;&#x003b4;TCR signal strength had profound effects not only on &#x003b1;&#x003b2;/&#x003b3;&#x003b4; lineage choice, but also on &#x003b3;&#x003b4; thymocyte maturation and &#x003b3;&#x003b4; T cell effector function. These results indicate that the cellular levels of Lck and Fyn play a role in regulating the strength of the &#x003b3;&#x003b4;TCR signaling response at different stages in the life of the &#x003b3;&#x003b4; T cell.</p></abstract><counts><page-count count="11"/></counts></article-meta></front><body><sec id="s1"><title>Introduction</title><p>Signaling by the TCR is required at multiple stages in the life of a T cell. In the thymus, TCR signaling is necessary for lineage commitment and repertoire selection, while in the periphery, TCR signaling is necessary for maintenance of the peripheral T cell pool and for activation and differentiation of mature T cells. Lck and Fyn, two members of the Src family of tyrosine kinases (SFKs), are involved in initiating the TCR-coupled signaling cascade <xref ref-type="bibr" rid="pone.0008899-Palacios1">&#x0005b;1&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0008899-Salmond1">&#x0005b;2&#x0005d;</xref>. Following TCR engagement, Lck and/or Fyn phosphorylate the tyrosines within the ITAMs of the CD3 and TCR&#x003b6; chains. This proximal signaling event leads to the recruitment of other signaling molecules to the TCR signaling complex and to the subsequent activation of signaling pathways that ultimately lead to the nucleus and initiation of gene transcription.</p><p>It is generally accepted that both Lck and Fyn positively regulate signal transduction by the &#x003b1;&#x003b2;TCR because, in the absence of either one of these SFKs, &#x003b1;&#x003b2;TCR signaling responses are impaired following anti-CD3 mAb stimulation <xref ref-type="bibr" rid="pone.0008899-Appleby1">&#x0005b;3&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0008899-Trobridge1">&#x0005b;9&#x0005d;</xref>. However, it has also been shown that Lck and Fyn localize to different subcellular compartments <xref ref-type="bibr" rid="pone.0008899-Ley1">&#x0005b;10&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0008899-Yasuda1">&#x0005b;11&#x0005d;</xref> and have different substrates <xref ref-type="bibr" rid="pone.0008899-Yasuda1">&#x0005b;11&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0008899-Zamoyska1">&#x0005b;12&#x0005d;</xref>, suggesting that they have discrete functions during &#x003b1;&#x003b2; T cell activation. This idea is supported by the disparate phenotypes of Lck- and Fyn-deficient mice. In Lck<sup>&#x02212;/&#x02212;</sup> mice, thymus cellularity is severely reduced, thymocyte development is almost completely blocked at the CD4<sup>&#x0002b;</sup>CD8<sup>&#x0002b;</sup> (double-positive; DP) stage, and very few mature &#x003b1;&#x003b2;TCR<sup>&#x0002b;</sup> cells are detected in peripheral lymphoid tissues <xref ref-type="bibr" rid="pone.0008899-Zamoyska1">&#x0005b;12&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0008899-Groves1">&#x0005b;14&#x0005d;</xref>. In contrast, Fyn<sup>&#x02212;/&#x02212;</sup> mice exhibit a mild defect in &#x003b1;&#x003b2; T cell development, as shown by the fact that Fyn<sup>&#x02212;/&#x02212;</sup> thymocytes, when <italic>in vitro</italic> stimulated, do not flux calcium or proliferate as well as wild-type (WT) thymocytes <xref ref-type="bibr" rid="pone.0008899-Appleby1">&#x0005b;3&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0008899-Stein1">&#x0005b;5&#x0005d;</xref>. Despite this signaling defect in the thymus, equivalent numbers of &#x003b1;&#x003b2; T cells are found in the periphery of Fyn<sup>&#x02212;/&#x02212;</sup> and WT mice <xref ref-type="bibr" rid="pone.0008899-Appleby1">&#x0005b;3&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0008899-Stein1">&#x0005b;5&#x0005d;</xref>.</p><p>While recent studies have confirmed that Lck functions primarily as a positive regulator of &#x003b1;&#x003b2;TCR signaling <xref ref-type="bibr" rid="pone.0008899-Legname1">&#x0005b;15&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0008899-Seddon1">&#x0005b;17&#x0005d;</xref>, evidence is accumulating in support of Fyn acting as a negative regulator of &#x003b1;&#x003b2;TCR signaling. First, it has been shown that Fyn is responsible for phosphorylating the adaptor protein, phosphoprotein associated with glycolipid-enriched membranes or PAG, in both resting thymocytes and T cells <xref ref-type="bibr" rid="pone.0008899-Yasuda1">&#x0005b;11&#x0005d;</xref>. Once phosphorylated, PAG then recruits Csk, an inhibitor of SFKs <xref ref-type="bibr" rid="pone.0008899-Brdicka1">&#x0005b;18&#x0005d;</xref>. Recruitment of Csk to phosphorylated PAG is required for optimal Csk kinase activity because, in the absence of Fyn, there is reduced phosphorylation of PAG and reduced Csk kinase activity <xref ref-type="bibr" rid="pone.0008899-Yasuda1">&#x0005b;11&#x0005d;</xref>. Therefore, by indirectly controlling the activity of the inhibitor Csk, Fyn may negatively regulate the activation threshold of &#x003b1;&#x003b2; T cells <xref ref-type="bibr" rid="pone.0008899-Yasuda1">&#x0005b;11&#x0005d;</xref>. It has also been shown that CD8<sup>&#x0002b;</sup> T cells from Fyn<sup>&#x02212;/&#x02212;</sup> F5 &#x003b1;&#x003b2;TCR Tg mice are hyperresponsive in comparison to CD8<sup>&#x0002b;</sup> T cells from WT F5 &#x003b1;&#x003b2;TCR Tg mice following <italic>in vitro</italic> stimulation with peptide and APCs <xref ref-type="bibr" rid="pone.0008899-Filby1">&#x0005b;19&#x0005d;</xref>. This hyperresponsiveness is manifested as enhanced proliferation, increased IL-2 production and more effective cytolytic activity <xref ref-type="bibr" rid="pone.0008899-Filby1">&#x0005b;19&#x0005d;</xref>. CD4<sup>&#x0002b;</sup> T cells from Fyn<sup>&#x02212;/&#x02212;</sup> DO11.10 &#x003b1;&#x003b2;TCR Tg mice, however, do not display increased proliferation compared to CD4<sup>&#x0002b;</sup> T cells from WT DO11.10 &#x003b1;&#x003b2;TCR Tg mice when stimulated, either <italic>in vitro</italic> or <italic>in vivo</italic>, with peptide and APCs <xref ref-type="bibr" rid="pone.0008899-Mamchak1">&#x0005b;20&#x0005d;</xref>. Nonetheless, when activated under the appropriate priming conditions, CD4<sup>&#x0002b;</sup> T cells from Fyn<sup>&#x02212;/&#x02212;</sup> DO11.10 &#x003b1;&#x003b2;TCR Tg mice produce significantly more IL-4 or IFN&#x003b3; than CD4<sup>&#x0002b;</sup> T cells from WT DO11.10 &#x003b1;&#x003b2;TCR Tg mice <xref ref-type="bibr" rid="pone.0008899-Mamchak1">&#x0005b;20&#x0005d;</xref>. Taken together, these findings suggest that Fyn negatively regulates the &#x003b1;&#x003b2;TCR signaling response.</p><p>Since studies investigating the functions of Lck and Fyn have focused primarily on &#x003b1;&#x003b2; T cells, it is not known whether their functional dichotomy is observed in only &#x003b1;&#x003b2; T lineage cells or in both &#x003b1;&#x003b2; and &#x003b3;&#x003b4; T lineage cells. Analyses of Lck<sup>&#x02212;/&#x02212;</sup> and Lck<sup>&#x02212;/&#x02212;</sup> Fyn<sup>&#x02212;/&#x02212;</sup> mice have in fact revealed differences in the requirements for these SFKs in &#x003b1;&#x003b2; and &#x003b3;&#x003b4; T cell development. In Lck<sup>&#x02212;/&#x02212;</sup> mice, the number of thymic and peripheral &#x003b3;&#x003b4; T cells is only modestly reduced compared to their numbers in WT mice <xref ref-type="bibr" rid="pone.0008899-Molina1">&#x0005b;13&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0008899-Groves1">&#x0005b;14&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0008899-vanOers2">&#x0005b;21&#x0005d;</xref>. Moreover, in Lck<sup>&#x02212;/&#x02212;</sup> Fyn<sup>&#x02212;/&#x02212;</sup> mice, in which &#x003b1;&#x003b2; T cell development is completely abrogated, a small number of &#x003b3;&#x003b4;TCR<sup>&#x0002b;</sup> cells do develop and can be detected in secondary lymphoid tissues, the small intestine, and the epidermis <xref ref-type="bibr" rid="pone.0008899-vanOers2">&#x0005b;21&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0008899-Page1">&#x0005b;22&#x0005d;</xref>. These differential requirements for Lck and Fyn in &#x003b1;&#x003b2; and &#x003b3;&#x003b4; T cell development suggest that these SFKs may have different functions in &#x003b1;&#x003b2;- and &#x003b3;&#x003b4;TCR signal transduction. To investigate this, we evaluated the individual roles of Lck and Fyn in the development and function of &#x003b3;&#x003b4; lineage cells. Here, we report that Lck and Fyn expression levels vary in &#x003b3;&#x003b4; lineage cells depending on their stage in development, with thymic &#x003b3;&#x003b4; T cells expressing relatively high levels of Lck and Fyn and peripheral &#x003b3;&#x003b4; T cells expressing relatively low levels of Lck and Fyn. These differences in the cellular levels of Lck and Fyn play a role in regulating the strength of the &#x003b3;&#x003b4;TCR signaling response at the different developmental stages because, when we reduced Lck or Fyn expression levels by using Lck<sup>&#x0002b;/&#x02212;</sup> and Fyn<sup>&#x0002b;/&#x02212;</sup> mice, we observed significant effects on &#x003b1;&#x003b2;/&#x003b3;&#x003b4; lineage choice, &#x003b3;&#x003b4; thymocyte maturation, and &#x003b3;&#x003b4; T cell effector function. Moreover, because reducing the levels of Lck or Fyn altered the &#x003b3;&#x003b4;TCR signaling response, such that low Lck levels weakened &#x003b3;&#x003b4;TCR signal strength and low Fyn levels augmented &#x003b3;&#x003b4;TCR signal strength, we conclude that Lck and Fyn have similar functions in &#x003b1;&#x003b2;- and &#x003b3;&#x003b4;TCR signal transduction, with Lck serving to amplify the TCR signal and Fyn serving to dampen the TCR signal.</p></sec><sec id="s2"><title>Results</title><sec id="s2a"><title>Expression Pattern of Lck and Fyn in &#x003b3;&#x003b4; Lineage Cells</title><p>Although it is generally accepted that &#x003b3;&#x003b4; T cells express Lck and Fyn, this idea is based more on indirect evidence from studies investigating &#x003b3;&#x003b4; T cell development in Lck- or Fyn-deficient mice <xref ref-type="bibr" rid="pone.0008899-Molina1">&#x0005b;13&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0008899-Groves1">&#x0005b;14&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0008899-vanOers2">&#x0005b;21&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0008899-Penninger1">&#x0005b;23&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0008899-Kawai1">&#x0005b;24&#x0005d;</xref> than on a direct demonstration of expression <xref ref-type="bibr" rid="pone.0008899-Buckland1">&#x0005b;25&#x0005d;</xref>. To resolve this, we developed an intracellular (i.c.) flow cytometric assay to measure and compare the relative levels of Lck and Fyn in &#x003b1;&#x003b2; and &#x003b3;&#x003b4; lineage cells from wild-type (WT) mice. Using Lck<sup>&#x02212;/&#x02212;</sup> and Fyn<sup>&#x02212;/&#x02212;</sup> cells as negative staining controls, we found that both Lck and Fyn are expressed in DN &#x003b3;&#x003b4; thymocytes and peripheral DN &#x003b3;&#x003b4; T cells (<xref ref-type="fig" rid="pone-0008899-g001">Fig. 1A</xref>). On average, DN &#x003b3;&#x003b4; thymocytes expressed Lck and Fyn at higher levels than DP and mature CD4<sup>&#x0002b;</sup> thymocytes, whereas peripheral DN &#x003b3;&#x003b4; T cells expressed Lck at levels comparable to those in CD4<sup>&#x0002b;</sup> T cells and Fyn at levels lower than those in CD4<sup>&#x0002b;</sup> T cells (<xref ref-type="fig" rid="pone-0008899-g001">Fig. 1A</xref>). When Lck and Fyn expression levels were compared between thymic and peripheral &#x003b3;&#x003b4; T cells, we found that both SFKs are expressed at significantly higher levels in DN &#x003b3;&#x003b4; thymocytes than in DN &#x003b3;&#x003b4; T cells (<xref ref-type="fig" rid="pone-0008899-g001">Fig. 1B&#x02013;C</xref>). This finding suggested that the expression levels of both Lck and Fyn are down-regulated once &#x003b3;&#x003b4; T cells emigrate from the thymus to the secondary lymphoid organs. This same phenomenon was also observed for &#x003b1;&#x003b2; lineage cells; however, the degree of reduction in Lck and Fyn expression levels between the thymus and LN was greater for &#x003b3;&#x003b4; lineage cells than &#x003b1;&#x003b2; lineage cells (<xref ref-type="fig" rid="pone-0008899-g001">Fig. 1C</xref> and data not shown). Taken together, these data indicated that immature and mature &#x003b3;&#x003b4; lineage cells express Lck and Fyn and that the expression of these SFKs is dynamic during &#x003b3;&#x003b4; T cell development and maturation.</p><fig id="pone-0008899-g001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0008899.g001</object-id><label>Figure 1</label><caption><title>Flow cytometric analysis of the intracellular levels of Lck and Fyn in &#x003b3;&#x003b4; lineage cells.</title><p>A. Histograms show representative staining of the i.c. levels of Lck and Fyn in gated populations of DP thymocytes and of thymic and LN CD4<sup>&#x0002b;</sup> CD3<sup>&#x0002b;</sup> and DN &#x003b3;&#x003b4;TCR<sup>&#x0002b;</sup> cells from WT (B6) mice. Staining of cells from Lck<sup>&#x02212;/&#x02212;</sup> and Fyn<sup>&#x02212;/&#x02212;</sup> mice are shown as negative controls for i.c. staining of Lck and Fyn, respectively. B. Comparison of the relative expression levels of Lck and Fyn in gated DN &#x003b3;&#x003b4;TCR<sup>&#x0002b;</sup> thymocytes and LN cells. C. Quantifying the change in the relative expression levels of Lck and Fyn in DN &#x003b3;&#x003b4;TCR<sup>&#x0002b;</sup> thymocytes and LN cells and, for comparison, CD4<sup>&#x0002b;</sup> CD3<sup>&#x0002b;</sup> thymocytes and LN cells. Lck and Fyn expression levels in immature and mature subsets were normalized to those of DP thymocytes, as this population had, in every experiment, consistently lower levels of Lck and Fyn than any other thymocyte or T cell subset (see A). Data are presented as fold change relative to DP thymocytes (set to 1). Data are representative of at least 6 independent experiments. Bars represent mean &#x000b1; SEM. &#x0002a;<italic>p&#x02264;0.05</italic>, &#x0002a;&#x0002a;<italic>p&#x02264;0.01</italic>, #<italic>p&#x02264;0.001</italic>.</p></caption><graphic xlink:href="pone.0008899.g001"/></fig></sec><sec id="s2b"><title>Polyclonal &#x003b3;&#x003b4; T Cell Development in Lck<sup>&#x0002b;/&#x02212;</sup> and Fyn<sup>&#x0002b;/&#x02212;</sup> Mice</title><p>Because DN &#x003b3;&#x003b4; thymocytes expressed higher levels of Lck and Fyn than mature DN &#x003b3;&#x003b4; T cells, we sought to determine whether high levels of Lck or Fyn were required for &#x003b3;&#x003b4; lineage commitment and/or development in the thymus. To investigate this, we reduced the expression levels of Lck or Fyn during T cell development by using Lck<sup>&#x0002b;/&#x02212;</sup> and Fyn<sup>&#x0002b;/&#x02212;</sup> mice. To verify that protein expression was reduced in the heterozygous mice, we compared the relative expression levels of Lck and Fyn in immature and mature CD4<sup>&#x0002b;</sup> lineage cells from Lck<sup>&#x0002b;/&#x02212;</sup> and Fyn<sup>&#x0002b;/&#x02212;</sup> mice with those from WT mice. As expected, we observed a 50&#x00025; reduction in Lck expression levels in Lck<sup>&#x0002b;/&#x02212;</sup> mice and a 50&#x00025; reduction in Fyn expression levels in Fyn<sup>&#x0002b;/&#x02212;</sup> mice (<xref ref-type="fig" rid="pone-0008899-g002">Fig. 2A</xref>). In addition, there was no compensatory increase in the expression of one SFK when expression of the other SFK was reduced (<xref ref-type="fig" rid="pone-0008899-g002">Fig. 2A</xref>).</p><fig id="pone-0008899-g002" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0008899.g002</object-id><label>Figure 2</label><caption><title>Effect of reducing Lck or Fyn levels on polyclonal &#x003b3;&#x003b4; T cell development.</title><p>A. Demonstration of the reduction of Lck or Fyn levels in CD4<sup>&#x0002b;</sup> thymocytes and LN cells from Lck<sup>&#x0002b;/&#x02212;</sup> and Fyn<sup>&#x0002b;/&#x02212;</sup> mice. The MFI of the i.c. levels of Lck and Fyn in CD4<sup>&#x0002b;</sup> lineage cells from heterozygous mice are expressed as a percentage of the MFI of the i.c. levels of Lck and Fyn in CD4<sup>&#x0002b;</sup> lineage cells from WT mice. A dashed line marks the expected 50&#x00025; reduction in WT Lck and Fyn levels. B. Number of DN &#x003b3;&#x003b4; thymocytes and LN &#x003b3;&#x003b4; T cells in WT, Lck<sup>&#x0002b;/&#x02212;</sup>, and Fyn<sup>&#x0002b;/&#x02212;</sup> mice. Data represent at least 6 mice per genotype. C. Quantifying the reduction of Lck and Fyn expression levels in DN &#x003b3;&#x003b4;TCR<sup>&#x0002b;</sup> thymocytes and LN cells from Lck<sup>&#x0002b;/&#x02212;</sup> and Fyn<sup>&#x0002b;/&#x02212;</sup> mice. The MFI of the i.c. levels of Lck and Fyn in &#x003b3;&#x003b4; lineage cells from heterozygous mice are expressed as a percentage of the MFI of the i.c. levels of Lck and Fyn in &#x003b3;&#x003b4; lineage cells from WT mice. A dashed line marks the expected 50&#x00025; reduction in WT Lck and Fyn levels. D. Relative expression levels of Lck and Fyn in WT DN2 (lin<sup>&#x02212;</sup> CD25<sup>&#x0002b;</sup> CD44<sup>&#x0002b;</sup>) thymocytes, where lin<sup>&#x02212;</sup> is defined as CD4<sup>&#x02212;</sup> CD8<sup>&#x02212;</sup> CD11b<sup>&#x02212;</sup> TCR&#x003b2;<sup>&#x02212;</sup> TCR&#x003b3;&#x003b4;<sup>&#x02212;</sup> CD19<sup>&#x02212;</sup> NK1.1<sup>&#x02212;</sup> IA<sup>b&#x02212;</sup> Ly6-G/Ly6-C<sup>&#x02212;</sup>. E. Quantifying the reduction of Lck and Fyn expression levels in DN2 thymocytes from Lck<sup>&#x0002b;/&#x02212;</sup> and Fyn<sup>&#x0002b;/&#x02212;</sup> mice. The MFI of the i.c. levels of Lck and Fyn in DN2 thymocytes from heterozygous mice are expressed as a percentage of the MFI of the i.c. levels of Lck and Fyn in DN2 thymocytes from WT mice. A dashed line marks the expected 50&#x00025; reduction in WT Lck and Fyn levels. In A, B, C, and E, the bars represent mean &#x000b1; SEM. &#x0002a;<italic>p&#x02264;0.05</italic>, &#x0002a;&#x0002a;<italic>p&#x02264;0.01</italic>, #<italic>p&#x02264;0.001</italic>.</p></caption><graphic xlink:href="pone.0008899.g002"/></fig><p>When &#x003b3;&#x003b4; T cell development was analyzed in Lck<sup>&#x0002b;/&#x02212;</sup> and Fyn<sup>&#x0002b;/&#x02212;</sup> mice, we observed no significant difference in the number of DN &#x003b3;&#x003b4; TCR<sup>&#x0002b;</sup> cells in the thymus and lymph nodes (LNs) of these mice compared to WT mice (<xref ref-type="fig" rid="pone-0008899-g002">Fig. 2B</xref>). Moreover, phenotypic analysis of the DN &#x003b3;&#x003b4; thymocytes and mature DN &#x003b3;&#x003b4; T cells from WT, Lck<sup>&#x0002b;/&#x02212;</sup> and Fyn<sup>&#x0002b;/&#x02212;</sup> mice revealed no appreciable differences in V&#x003b3; usage, TCR&#x003b3;&#x003b4; surface levels and cell surface phenotype (data not shown), indicating that reducing the expression levels of Lck or Fyn resulted in no apparent defect in the development of polyclonal &#x003b3;&#x003b4; T cells.</p><p>Because &#x003b3;&#x003b4; T cell development appeared not to be affected in Lck<sup>&#x0002b;/&#x02212;</sup> and Fyn<sup>&#x0002b;/&#x02212;</sup> mice, we examined the levels of Lck and Fyn in &#x003b3;&#x003b4; lineage cells of the heterozygous mice to determine whether they were reduced by 50&#x00025; as they were in &#x003b1;&#x003b2; lineage cells (<xref ref-type="fig" rid="pone-0008899-g002">Fig. 2A and C</xref>). We found that Lck levels were indeed reduced by 50&#x00025; in thymic and peripheral &#x003b3;&#x003b4; lineage cells from Lck<sup>&#x0002b;/&#x02212;</sup> mice (<xref ref-type="fig" rid="pone-0008899-g002">Fig. 2C</xref>). Fyn levels, on the other hand, were reduced to &#x0223c;60&#x00025; in immature and mature &#x003b3;&#x003b4; lineage cells from Fyn<sup>&#x0002b;/&#x02212;</sup> mice, which is significantly different from the expected 50&#x00025; (<xref ref-type="fig" rid="pone-0008899-g002">Fig. 2C</xref>). Since Fyn expression levels in &#x003b3;&#x003b4; lineage cells were not reduced to the expected 50&#x00025; in Fyn<sup>&#x0002b;/&#x02212;</sup> mice, we determined whether the thymic precursors in Lck<sup>&#x0002b;/&#x02212;</sup> and Fyn<sup>&#x0002b;/&#x02212;</sup> mice displayed a 50&#x00025; reduction in Lck and Fyn expression levels, respectively. To accomplish this, we compared Lck and Fyn expression levels in lineage-negative CD44<sup>&#x0002b;</sup>CD25<sup>&#x0002b;</sup> (DN2) thymocytes from WT, Lck<sup>&#x0002b;/&#x02212;</sup> and Fyn<sup>&#x0002b;/&#x02212;</sup> mice, as this thymocyte subset contains precursors that have the potential to develop into &#x003b1;&#x003b2; or &#x003b3;&#x003b4; lineage cells <xref ref-type="bibr" rid="pone.0008899-Petrie1">&#x0005b;26&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0008899-Ciofani1">&#x0005b;27&#x0005d;</xref>. We found that, while Lck expression levels were reduced to 50&#x00025; in Lck<sup>&#x0002b;/&#x02212;</sup> DN2 thymocytes, Fyn expression levels were only reduced to 85&#x00025; in Fyn<sup>&#x0002b;/&#x02212;</sup> DN2 thymocytes (<xref ref-type="fig" rid="pone-0008899-g002">Fig. 2D and E</xref>). These data demonstrated that although Fyn levels are reduced in thymic precursors and &#x003b3;&#x003b4; lineage cells from Fyn<sup>&#x0002b;/&#x02212;</sup> mice, they are not reduced by 50&#x00025; as they are in &#x003b1;&#x003b2; lineage cells.</p></sec><sec id="s2c"><title>Effect of Reducing Lck or Fyn Levels on the Commitment and Development of &#x003b3;&#x003b4; Lineage Cells</title><p>Another reason why we may not have observed any defects in &#x003b3;&#x003b4; T cell development in Lck<sup>&#x0002b;/&#x02212;</sup> and Fyn<sup>&#x0002b;/&#x02212;</sup> mice is because thymocyte development and selection are able to compensate for alterations in &#x003b3;&#x003b4;TCR signal transduction, which may result from reductions in Lck or Fyn expression. To address this, we mated a &#x003b3;&#x003b4;TCR transgene onto Lck<sup>&#x0002b;/&#x02212;</sup> and Fyn<sup>&#x0002b;/&#x02212;</sup> genetic backgrounds to determine whether fixing the specificity of the &#x003b3;&#x003b4;TCR revealed defects in &#x003b1;&#x003b2;/&#x003b3;&#x003b4; lineage choice and/or &#x003b3;&#x003b4; T cell development. For these experiments, we used the V&#x003b3;6/J&#x003b3;1/C&#x003b3;1 and V&#x003b4;1/D&#x003b4;1/J&#x003b4;2/C&#x003b4; transgenic (&#x003b3;&#x003b4;TCR Tg) mouse <xref ref-type="bibr" rid="pone.0008899-Sim1">&#x0005b;28&#x0005d;</xref>, which we have previously used to study &#x003b1;&#x003b2;/&#x003b3;&#x003b4; lineage choice, &#x003b3;&#x003b4; T cell development and &#x003b3;&#x003b4;TCR signal transduction <xref ref-type="bibr" rid="pone.0008899-Hayes1">&#x0005b;29&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0008899-Laird1">&#x0005b;31&#x0005d;</xref>. It is important to note that, although V&#x003b3;6/V&#x003b4;1<sup>&#x0002b;</sup> &#x003b3;&#x003b4; T cells are only generated in the fetal thymus of a WT (non-&#x003b3;&#x003b4;TCR Tg) mouse <xref ref-type="bibr" rid="pone.0008899-Sim1">&#x0005b;28&#x0005d;</xref>, the V&#x003b3;6/V&#x003b4;1<sup>&#x0002b;</sup> &#x003b3;&#x003b4; T cells generated in the &#x003b3;&#x003b4;TCR Tg mouse represent adult &#x003b3;&#x003b4; T cells, as they express the panel of &#x003b3;&#x003b4;-biased genes <xref ref-type="bibr" rid="pone.0008899-Laird1">&#x0005b;31&#x0005d;</xref> typical of adult but not fetal &#x003b3;&#x003b4; T cell populations <xref ref-type="bibr" rid="pone.0008899-Pennington1">&#x0005b;32&#x0005d;</xref>. Moreover, one of the advantages of using this &#x003b3;&#x003b4;TCR Tg mouse model to study &#x003b1;&#x003b2;/&#x003b3;&#x003b4; lineage choice is that the rearranged TCR&#x003b3; and &#x02013;&#x003b4; chains are expressed early during T cell development prior to TCR&#x003b2; expression and, as a consequence, the &#x003b1;&#x003b2;/&#x003b3;&#x003b4; lineage decision is mediated exclusively by the &#x003b3;&#x003b4;TCR <xref ref-type="bibr" rid="pone.0008899-Hayes1">&#x0005b;29&#x0005d;</xref>.</p><p>By fixing the specificity of the &#x003b3;&#x003b4;TCR, we observed significant effects on the &#x003b1;&#x003b2;/&#x003b3;&#x003b4; lineage fate decision when the levels of Lck but not Fyn were reduced. In WT &#x003b3;&#x003b4;TCR Tg mice, equivalent numbers of DN &#x003b3;&#x003b4;TCR<sup>&#x0002b;</sup> thymocytes (&#x003b3;&#x003b4; lineage) and DP thymocytes (&#x003b1;&#x003b2; lineage cells) are generated (<xref ref-type="fig" rid="pone-0008899-g003">Fig. 3A&#x02013;B</xref>). Reducing Lck expression resulted in a striking 4-fold increase in thymus cell number compared to WT &#x003b3;&#x003b4;TCR Tg mice, most likely due to the significant increase in the percentage of DP thymocytes (<xref ref-type="fig" rid="pone-0008899-g003">Fig. 3A</xref>). Consequently, the number of &#x003b1;&#x003b2; lineage cells in Lck<sup>&#x0002b;/&#x02212;</sup> &#x003b3;&#x003b4;TCR Tg mice was significantly higher than that in WT &#x003b3;&#x003b4;TCR Tg mice (<xref ref-type="fig" rid="pone-0008899-g003">Fig. 3B</xref>). These findings are consistent with those of a previous study, in which &#x003b3;&#x003b4;TCR-dependent generation of DP thymocytes but not of DN &#x003b3;&#x003b4;TCR<sup>&#x0002b;</sup> thymocytes was observed in the absence of Lck expression <xref ref-type="bibr" rid="pone.0008899-Haks1">&#x0005b;33&#x0005d;</xref>. In contrast, reducing Fyn levels had no effect on total thymus cell number. Nonetheless, we did observe a decrease in both the percentage and number of DP thymocytes in Fyn<sup>&#x0002b;/&#x02212;</sup> &#x003b3;&#x003b4;TCR Tg mice, although these differences were not statistically significant from the percentage and number of DP thymocytes in WT &#x003b3;&#x003b4;TCR Tg mice (<xref ref-type="fig" rid="pone-0008899-g003">Fig. 3A&#x02013;B</xref>). Interestingly, despite the changes in the numbers of DP thymocytes in the heterozygous mice, the numbers of DN &#x003b3;&#x003b4;TCR<sup>&#x0002b;</sup> thymocytes, or &#x003b3;&#x003b4; lineage cells, in Lck<sup>&#x0002b;/&#x02212;</sup> &#x003b3;&#x003b4;TCR Tg and Fyn<sup>&#x0002b;/&#x02212;</sup> &#x003b3;&#x003b4;TCR Tg mice were comparable to their number in WT &#x003b3;&#x003b4;TCR Tg mice (<xref ref-type="fig" rid="pone-0008899-g003">Fig. 3A&#x02013;B</xref>).</p><fig id="pone-0008899-g003" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0008899.g003</object-id><label>Figure 3</label><caption><title>Effect of reducing Lck or Fyn levels on &#x003b1;&#x003b2;/&#x003b3;&#x003b4; lineage commitment and &#x003b3;&#x003b4; T cell development.</title><p>A. Dot plots show representative CD4 versus CD8 staining profiles for WT &#x003b3;&#x003b4;TCR Tg, Lck<sup>&#x0002b;/&#x02212;</sup> &#x003b3;&#x003b4;TCR Tg, and Fyn<sup>&#x0002b;/&#x02212;</sup> &#x003b3;&#x003b4;TCR Tg thymocytes. Numbers in the quadrants represent percentage of cells in each quadrant. The mean thymus cell number &#x000b1; SEM for each genotype are displayed above the respective two-color plot. B. Mean number of DN (DN &#x003b3;&#x003b4;TCR<sup>&#x0002b;</sup>; &#x003b3;&#x003b4; lineage) and DP (&#x003b1;&#x003b2; lineage) thymocytes in WT &#x003b3;&#x003b4;TCR Tg, Lck<sup>&#x0002b;/&#x02212;</sup> &#x003b3;&#x003b4;TCR Tg and Fyn<sup>&#x0002b;/&#x02212;</sup> &#x003b3;&#x003b4;TCR Tg mice. Data represent at least 6 mice per genotype. C. Mean number of DN &#x003b3;&#x003b4; T cells in the LNs of WT &#x003b3;&#x003b4;TCR Tg, Lck<sup>&#x0002b;/&#x02212;</sup> &#x003b3;&#x003b4;TCR Tg and Fyn<sup>&#x0002b;/&#x02212;</sup> &#x003b3;&#x003b4;TCR Tg mice. Data represent at least 5 mice per genotype. In B and C, the bars represent mean &#x000b1; SEM. &#x0002a;<italic>p&#x02264;0.05</italic>, #<italic>p&#x02264;0.001</italic>.</p></caption><graphic xlink:href="pone.0008899.g003"/></fig><p>It has previously been shown that genetic manipulation of &#x003b3;&#x003b4;TCR signal strength affects &#x003b1;&#x003b2;/&#x003b3;&#x003b4; lineage choice in a consistent manner. Namely, when the &#x003b3;&#x003b4;TCR signaling response is strengthened, &#x003b3;&#x003b4; lineage fate is favored and, conversely, when the &#x003b3;&#x003b4;TCR signaling response is weakened, &#x003b1;&#x003b2; lineage fate is favored <xref ref-type="bibr" rid="pone.0008899-Hayes1">&#x0005b;29&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0008899-Haks1">&#x0005b;33&#x0005d;</xref>. Our finding that the number of &#x003b1;&#x003b2; lineage cells was significantly increased in Lck<sup>&#x0002b;/&#x02212;</sup> &#x003b3;&#x003b4;TCR Tg mice compared to WT &#x003b3;&#x003b4;TCR Tg mice suggested that reducing Lck levels weakened &#x003b3;&#x003b4;TCR signal strength. Surprisingly, this increase in the number of DP thymocytes was not accompanied by a corresponding decrease in the number of DN &#x003b3;&#x003b4; thymocytes in Lck<sup>&#x0002b;/&#x02212;</sup> &#x003b3;&#x003b4;TCR Tg (<xref ref-type="fig" rid="pone-0008899-g003">Fig. 3B</xref>). We reasoned that the number of DN &#x003b3;&#x003b4; thymocytes in Lck<sup>&#x0002b;/&#x02212;</sup> &#x003b3;&#x003b4;TCR Tg mice may not reflect the number of thymocytes that adopted the &#x003b3;&#x003b4; fate but instead reflected an expansion of the thymocytes that already adopted the &#x003b3;&#x003b4; fate. To investigate this, we compared the proliferative status of DN &#x003b3;&#x003b4; thymocytes in WT &#x003b3;&#x003b4;TCR Tg, Lck<sup>&#x0002b;/&#x02212;</sup> &#x003b3;&#x003b4;TCR Tg, and Fyn<sup>&#x0002b;/&#x02212;</sup> &#x003b3;&#x003b4;TCR Tg mice by measuring their expression of the Ki-67 Ag, which is a marker of actively cycling cells <xref ref-type="bibr" rid="pone.0008899-Gerdes1">&#x0005b;34&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0008899-Bruno1">&#x0005b;35&#x0005d;</xref>. We found that the frequency of Ki67<sup>&#x0002b;</sup> DN &#x003b3;&#x003b4; thymocytes in Lck<sup>&#x0002b;/&#x02212;</sup> &#x003b3;&#x003b4;TCR Tg mice was significantly higher than the frequency of Ki67<sup>&#x0002b;</sup> DN &#x003b3;&#x003b4; thymocytes in WT &#x003b3;&#x003b4;TCR Tg and Fyn<sup>&#x0002b;/&#x02212;</sup> &#x003b3;&#x003b4;TCR Tg mice (<xref ref-type="table" rid="pone-0008899-t001">Table 1</xref>). These data suggested that the number of DN &#x003b3;&#x003b4; thymocytes in Lck<sup>&#x0002b;/&#x02212;</sup> &#x003b3;&#x003b4;TCR Tg mice does not reflect the number of thymocytes that adopted the &#x003b3;&#x003b4; fate.</p><table-wrap id="pone-0008899-t001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0008899.t001</object-id><label>Table 1</label><caption><title>Percentage of Ki-67<sup>&#x0002b;</sup> DN &#x003b3;&#x003b4;TCR<sup>&#x0002b;</sup> thymocytes<xref ref-type="table-fn" rid="nt101">a</xref>.</title></caption><alternatives><graphic id="pone-0008899-t001-1" xlink:href="pone.0008899.t001"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1">Genotype</td><td align="left" rowspan="1" colspan="1">&#x00025; Ki-67<sup>&#x0002b;</sup> DN &#x003b3;&#x003b4;TCR<sup>&#x0002b;</sup></td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">WT &#x003b3;&#x003b4;TCR Tg</td><td align="left" rowspan="1" colspan="1">32.6&#x000b1;1.2</td></tr><tr><td align="left" rowspan="1" colspan="1">Lck<sup>&#x0002b;/&#x02212;</sup> &#x003b3;&#x003b4;TCR Tg</td><td align="left" rowspan="1" colspan="1">43.7&#x000b1;6.0<xref ref-type="table-fn" rid="nt102">&#x0002a;&#x0002a;</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Fyn<sup>&#x0002b;/&#x02212;</sup> &#x003b3;&#x003b4;TCR Tg</td><td align="left" rowspan="1" colspan="1">32.3&#x000b1;1.8</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="nt101"><label/><p><italic><sup>a</sup></italic>Ki-67 expression marks cells in late G<sub>1</sub> phase through mitosis and is used as marker of active cell cycling.</p></fn><fn id="nt102"><label/><p>&#x0002a;&#x0002a;<italic>p&#x02264;0.01</italic>.</p></fn></table-wrap-foot></table-wrap><p>Next, we compared the expression levels of the &#x003b3;&#x003b4;TCR and CD5 on the surface of DN &#x003b3;&#x003b4; thymocytes from WT &#x003b3;&#x003b4;TCR Tg, Lck<sup>&#x0002b;/&#x02212;</sup> &#x003b3;&#x003b4;TCR Tg, and Fyn<sup>&#x0002b;/&#x02212;</sup> &#x003b3;&#x003b4;TCR Tg mice to gauge the effects of reducing Lck or Fyn levels on the phenotype of the cells choosing the &#x003b3;&#x003b4; lineage. When we examined &#x003b3;&#x003b4;TCR and CD5 surface levels on the DN &#x003b3;&#x003b4; thymocytes that were generated in WT &#x003b3;&#x003b4;TCR Tg, Lck<sup>&#x0002b;/&#x02212;</sup> &#x003b3;&#x003b4;TCR Tg and Fyn<sup>&#x0002b;/&#x02212;</sup> &#x003b3;&#x003b4;TCR Tg mice, we found that DN &#x003b3;&#x003b4; thymocytes in the three genotypes expressed different levels of the &#x003b3;&#x003b4;TCR but equivalent levels of CD5. Specifically, Lck<sup>&#x0002b;/&#x02212;</sup> &#x003b3;&#x003b4; thymocytes expressed significantly higher levels of the &#x003b3;&#x003b4;TCR than WT &#x003b3;&#x003b4; thymocytes, whereas Fyn<sup>&#x0002b;/&#x02212;</sup> &#x003b3;&#x003b4; thymocytes expressed significantly lower levels of the &#x003b3;&#x003b4;TCR than WT &#x003b3;&#x003b4; thymocytes (<xref ref-type="fig" rid="pone-0008899-g004">Fig. 4A</xref>). These data suggested that reducing Lck expression levels weakened &#x003b3;&#x003b4;TCR signal strength to the extent that immature thymocytes expressing relatively high levels of the &#x003b3;&#x003b4;TCR adopted the &#x003b3;&#x003b4; fate. Conversely, reducing Fyn expression levels augmented &#x003b3;&#x003b4;TCR signal strength to where immature thymocytes expressing relatively low levels of the &#x003b3;&#x003b4;TCR adopted the &#x003b3;&#x003b4; fate.</p><fig id="pone-0008899-g004" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0008899.g004</object-id><label>Figure 4</label><caption><title>Phenotypic analysis of &#x003b3;&#x003b4; lineage cells from Lck<sup>&#x0002b;/&#x02212;</sup> &#x003b3;&#x003b4;TCR Tg and Fyn<sup>&#x0002b;/&#x02212;</sup> &#x003b3;&#x003b4;TCR Tg mice.</title><p>A. Comparison of CD5 and TCR&#x003b3;&#x003b4; surface levels on DN &#x003b3;&#x003b4; thymocytes from WT &#x003b3;&#x003b4;TCR Tg, Lck<sup>&#x0002b;/&#x02212;</sup> &#x003b3;&#x003b4;TCR Tg and Fyn<sup>&#x0002b;/&#x02212;</sup> &#x003b3;&#x003b4;TCR Tg mice. MFIs of CD5 and TCR&#x003b3;&#x003b4; surface levels on DN &#x003b3;&#x003b4; thymocytes from heterozygous mice are presented as a percentage of the MFIs of CD5 and TCR&#x003b3;&#x003b4; surface levels on DN &#x003b3;&#x003b4; thymocytes from WT &#x003b3;&#x003b4;TCR Tg mice. Data represent at least 6 mice per genotype. B. Percentage of CD24<sup>&#x0002b;</sup> and CD44<sup>&#x0002b;</sup> &#x003b3;&#x003b4; T cells in WT &#x003b3;&#x003b4;TCR Tg, Lck<sup>&#x0002b;/&#x02212;</sup> &#x003b3;&#x003b4;TCR Tg and Fyn<sup>&#x0002b;/&#x02212;</sup> &#x003b3;&#x003b4;TCR Tg mice. Data represent at least 3 mice per genotype. C. Comparison of CD5 and TCR&#x003b3;&#x003b4; surface levels on DN &#x003b3;&#x003b4; T cells from the LNs of WT &#x003b3;&#x003b4;TCR Tg, Lck<sup>&#x0002b;/&#x02212;</sup> &#x003b3;&#x003b4;TCR Tg and Fyn<sup>&#x0002b;/&#x02212;</sup> &#x003b3;&#x003b4;TCR Tg mice. MFIs of CD5 and TCR&#x003b3;&#x003b4; surface levels on peripheral DN &#x003b3;&#x003b4; T cells from heterozygous mice are presented as a percentage of the MFIs of CD5 and TCR&#x003b3;&#x003b4; surface levels on peripheral DN &#x003b3;&#x003b4; T cells from WT &#x003b3;&#x003b4;TCR Tg mice. Data represent at least 5 mice per genotype. In A, B, and C, the bars represent mean &#x000b1; SEM. &#x0002a;<italic>p&#x02264;0.05</italic>, &#x0002a;&#x0002a;<italic>p&#x02264;0.01</italic>, #<italic>p&#x02264;0.001</italic>.</p></caption><graphic xlink:href="pone.0008899.g004"/></fig><p>To investigate the effects of reducing the levels of Lck or Fyn on the maturation of &#x003b3;&#x003b4; T cells in the thymus and their subsequent ability to migrate to the periphery, we enumerated DN &#x003b3;&#x003b4; T cells in the LNs of WT &#x003b3;&#x003b4;TCR Tg, Lck<sup>&#x0002b;/&#x02212;</sup> &#x003b3;&#x003b4;TCR Tg, and Fyn<sup>&#x0002b;/&#x02212;</sup> &#x003b3;&#x003b4;TCR Tg mice. Compared to WT &#x003b3;&#x003b4;TCR Tg mice, we observed a significant decrease in the number of DN &#x003b3;&#x003b4; T cells in Lck<sup>&#x0002b;/&#x02212;</sup> &#x003b3;&#x003b4;TCR Tg mice but not in the number of DN &#x003b3;&#x003b4; T cells in Fyn<sup>&#x0002b;/&#x02212;</sup> &#x003b3;&#x003b4;TCR Tg mice (<xref ref-type="fig" rid="pone-0008899-g003">Fig. 3C</xref>). Consistent with the lower numbers of peripheral &#x003b3;&#x003b4; T cells in Lck<sup>&#x0002b;/&#x02212;</sup> &#x003b3;&#x003b4;TCR Tg mice was the finding that there were fewer DN &#x003b3;&#x003b4; T cells in these mice that expressed CD24, a marker of recent thymic emigrant &#x003b3;&#x003b4; T cells <xref ref-type="bibr" rid="pone.0008899-Tough1">&#x0005b;36&#x0005d;</xref>, and that there were more cells that expressed CD44, a marker of activated cells, memory cells, and/or cells undergoing homeostatic proliferation <xref ref-type="bibr" rid="pone.0008899-Tough1">&#x0005b;36&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0008899-Goldrath1">&#x0005b;38&#x0005d;</xref> (<xref ref-type="fig" rid="pone-0008899-g004">Fig. 4B</xref>). Moreover, we found that the &#x003b3;&#x003b4;TCR and CD5 surface levels that were noted among the DN &#x003b3;&#x003b4;TCR<sup>&#x0002b;</sup> thymocytes from the three genotypes were maintained on their respective peripheral &#x003b3;&#x003b4; T cells, with the exception that Lck<sup>&#x0002b;/&#x02212;</sup> &#x003b3;&#x003b4; T cells expressed significantly lower levels of CD5 than WT &#x003b3;&#x003b4; T cells (<xref ref-type="fig" rid="pone-0008899-g004">Fig. 4C</xref>). Therefore, although DN &#x003b3;&#x003b4; thymocytes were generated in Lck<sup>&#x0002b;/&#x02212;</sup> &#x003b3;&#x003b4;TCR Tg mice in numbers comparable to WT &#x003b3;&#x003b4;TCR Tg mice, these mice had reduced numbers of mature DN &#x003b3;&#x003b4; T cells. These data indicated that a reduction in Lck levels but not Fyn levels affects the maturation and/or survival of thymic &#x003b3;&#x003b4; T cells.</p></sec><sec id="s2d"><title>Effect of Reducing Lck or Fyn Levels on &#x003b3;&#x003b4; T Cell Effector Fate and Function</title><p>&#x003b3;&#x003b4; T cell effector fate has been shown to segregate with expression of specific surface antigens, specifically CD122<sup>&#x0002b;</sup> and/or CD27<sup>&#x0002b;</sup> &#x003b3;&#x003b4; T cells preferentially produce IFN&#x003b3; <xref ref-type="bibr" rid="pone.0008899-Jensen1">&#x0005b;39&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0008899-Ribot1">&#x0005b;40&#x0005d;</xref>, whereas IL-23R<sup>&#x0002b;</sup> &#x003b3;&#x003b4; T cells preferentially produce IL-17 <xref ref-type="bibr" rid="pone.0008899-Awashi1">&#x0005b;41&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0008899-Sutton1">&#x0005b;43&#x0005d;</xref>. Given these findings, we sought to determine whether reducing the levels of Lck or Fyn altered the ability of a &#x003b3;&#x003b4; T cell to become an IL-17- and/or IFN&#x003b3;-producing effector cell. To accomplish this, we chose to use our &#x003b3;&#x003b4;TCR Tg mouse model as it generates, on the WT background, 30-fold more DN &#x003b3;&#x003b4; T cells than non-&#x003b3;&#x003b4;TCR Tg mice <xref ref-type="bibr" rid="pone.0008899-Hayes2">&#x0005b;30&#x0005d;</xref>. This means that DN &#x003b3;&#x003b4; T cells can be analyzed without the concern that purification by positive selection using an anti-TCR&#x003b3;&#x003b4; mAb may crosslink the &#x003b3;&#x003b4;TCR and, in turn, pre-activate the &#x003b3;&#x003b4; T cell. First, we determined whether there were any differences in the percentages of &#x003b3;&#x003b4; T cells expressing CD122, CD27 or IL-23R among WT &#x003b3;&#x003b4;TCR Tg, Lck<sup>&#x0002b;/&#x02212;</sup> &#x003b3;&#x003b4;TCR Tg, and Fyn<sup>&#x0002b;/&#x02212;</sup> &#x003b3;&#x003b4;TCR Tg mice. We found that both Lck<sup>&#x0002b;/&#x02212;</sup> &#x003b3;&#x003b4;TCR Tg and Fyn<sup>&#x0002b;/&#x02212;</sup> &#x003b3;&#x003b4;TCR Tg mice had similar percentages of CD27<sup>&#x0002b;</sup> and CD27<sup>&#x02212;</sup> &#x003b3;&#x003b4; T cells as WT &#x003b3;&#x003b4;TCR Tg mice, but the percentages of CD27<sup>&#x0002b;</sup> cells co-expressing CD122<sup>&#x0002b;</sup> in both Lck<sup>&#x0002b;/&#x02212;</sup> &#x003b3;&#x003b4;TCR Tg and Fyn<sup>&#x0002b;/&#x02212;</sup> &#x003b3;&#x003b4;TCR Tg mice was reduced compared to WT &#x003b3;&#x003b4;TCR Tg mice (<xref ref-type="fig" rid="pone-0008899-g005">Fig. 5A</xref>). As CD122 expression by &#x003b3;&#x003b4; T cells is induced when the &#x003b3;&#x003b4;TCR interacts with its ligand in the thymus <xref ref-type="bibr" rid="pone.0008899-Jensen1">&#x0005b;39&#x0005d;</xref>, these results suggested that the selection and/or survival of CD122<sup>&#x0002b;</sup> &#x003b3;&#x003b4; T cells is impaired when Lck or Fyn levels are reduced. To evaluate IL-23R expression among WT, Lck<sup>&#x0002b;/&#x02212;</sup>, and Fyn<sup>&#x0002b;/&#x02212;</sup> &#x003b3;&#x003b4; T cells, we performed quantitative real-time RT-PCR analysis to detect transcription of <italic>IL12RB1</italic> and <italic>IL23R</italic>, which encode the two subunits of the IL-23R <xref ref-type="bibr" rid="pone.0008899-Parham1">&#x0005b;44&#x0005d;</xref>. No significant differences were noted in the relative amounts of <italic>IL12RB1</italic> and <italic>IL23R</italic> transcripts among WT, Lck<sup>&#x0002b;/&#x02212;</sup>, and Fyn<sup>&#x0002b;/&#x02212;</sup> &#x003b3;&#x003b4; T cells (<xref ref-type="fig" rid="pone-0008899-g005">Fig. 5B</xref>), indicating that the selection and/or survival of &#x003b3;&#x003b4; T cells with the potential to produce IL-17 is not affected when Lck or Fyn levels are reduced.</p><fig id="pone-0008899-g005" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0008899.g005</object-id><label>Figure 5</label><caption><title>Effect of reducing Lck or Fyn levels on &#x003b3;&#x003b4; T cell effector fate and function.</title><p>A. Dot plots showing representative CD122 versus CD27 staining profiles for DN &#x003b3;&#x003b4;TCR<sup>&#x0002b;</sup> LN cells from WT &#x003b3;&#x003b4;TCR Tg, Lck<sup>&#x0002b;/&#x02212;</sup> &#x003b3;&#x003b4;TCR Tg and Fyn<sup>&#x0002b;/&#x02212;</sup> &#x003b3;&#x003b4;TCR Tg mice. Numbers in the quadrants represent percentage of cells in that quadrant. The percentage of CD122<sup>&#x0002b;</sup> DN &#x003b3;&#x003b4; T cells is significantly lower in Fyn<sup>&#x0002b;/&#x02212;</sup> &#x003b3;&#x003b4;TCR Tg mice than in WT &#x003b3;&#x003b4;TCR Tg mice, <italic>p&#x02264;0.05</italic>. Data are representative of at least 6 mice per genotype. B. Quantitative real-time RT-PCR analysis of the relative transcript levels of <italic>IL12RB1</italic> and <italic>IL23R</italic> in purified peripheral DN &#x003b3;&#x003b4; T cells from WT &#x003b3;&#x003b4;TCR Tg, Lck<sup>&#x0002b;/&#x02212;</sup> &#x003b3;&#x003b4;TCR Tg and Fyn<sup>&#x0002b;/&#x02212;</sup> &#x003b3;&#x003b4;TCR Tg mice. Data are normalized to <italic>GAPDH</italic> and are presented as fold change over WT &#x003b3;&#x003b4; T cells (set to 1). Bars represent mean &#x000b1; SEM. Data represent 3 mice per genotype. C. Comparison of IL-17 and IFN&#x003b3; production by DN &#x003b3;&#x003b4;TCR<sup>&#x0002b;</sup> LN cells from WT &#x003b3;&#x003b4;TCR Tg, Lck<sup>&#x0002b;/&#x02212;</sup> &#x003b3;&#x003b4;TCR Tg and Fyn<sup>&#x0002b;/&#x02212;</sup> &#x003b3;&#x003b4;TCR Tg mice. LN cells from the three genotypes were <italic>in vitro</italic> stimulated with 1 or 5 &#x000b5;g/ml of immobilized anti-CD3 mAb or 5 &#x000b5;g/ml of immobilized hamster IgG. 16 h later, cells were harvested and cytokine production was assayed by i.c. flow cytometric analysis. Dot plots show representative i.c. staining for IFN&#x003b3; versus IL-17 in gated DN &#x003b3;&#x003b4;TCR<sup>&#x0002b;</sup> cells. Numbers in the quadrants represent percentage of cells in that quadrant. Data shown are representative of at least 3 mice per genotype. D. Comparison of the ability of DN &#x003b3;&#x003b4; T cells from WT &#x003b3;&#x003b4;TCR Tg, Lck<sup>&#x0002b;/&#x02212;</sup> &#x003b3;&#x003b4;TCR Tg and Fyn<sup>&#x0002b;/&#x02212;</sup> &#x003b3;&#x003b4;TCR Tg to produce TNF&#x003b1;. Lymph node cells from each genotype were <italic>in vitro</italic> stimulated with 5 &#x000b5;g/ml of immobilized anti-CD3 mAb or 5 &#x000b5;g/ml of immobilized hamster IgG. 48 h later, cytokine production was measured by i.c. flow cytometry. Dot plots show representative staining for i.c. TNF&#x003b1; versus TCR&#x003b3;&#x003b4; in gated DN &#x003b3;&#x003b4;TCR<sup>&#x0002b;</sup> cells. The percentage of TNF&#x003b1;-producing &#x003b3;&#x003b4; T cells for each genotype is shown. Data are representative of at least 4 mice per genotype.</p></caption><graphic xlink:href="pone.0008899.g005"/></fig><p>Next, we assessed cytokine production by WT, Lck<sup>&#x0002b;/&#x02212;</sup>, and Fyn<sup>&#x0002b;/&#x02212;</sup> &#x003b3;&#x003b4; T cells following CD3 crosslinking. Interestingly, we found that the percentages of WT, Lck<sup>&#x0002b;/&#x02212;</sup> and Fyn<sup>&#x0002b;/&#x02212;</sup> &#x003b3;&#x003b4; T cells producing IFN&#x003b3; at 16 h were equivalent to the percentages of CD122<sup>&#x0002b;</sup> CD27<sup>&#x0002b;</sup> &#x003b3;&#x003b4; T cells in each mouse (<xref ref-type="fig" rid="pone-0008899-g005">Fig. 5A and C</xref>). It is also important to note that the level of IFN&#x003b3; production, as measured by MFI, was 2 to 3-fold less in Lck<sup>&#x0002b;/&#x02212;</sup> and Fyn<sup>&#x0002b;/&#x02212;</sup> IFN&#x003b3;<sup>&#x0002b;</sup> &#x003b3;&#x003b4; T cells than in WT IFN&#x003b3;<sup>&#x0002b;</sup> &#x003b3;&#x003b4; T cells (<xref ref-type="fig" rid="pone-0008899-g005">Fig. 5C</xref> and data not shown). Moreover, when we compared the ability of WT, Lck<sup>&#x0002b;/&#x02212;</sup> and Fyn<sup>&#x0002b;/&#x02212;</sup> &#x003b3;&#x003b4; T cells to differentiate into IL-17-producing cells at 16 h, we detected considerably fewer Fyn<sup>&#x0002b;/&#x02212;</sup> IL-17<sup>&#x0002b;</sup> &#x003b3;&#x003b4; T cells than Lck<sup>&#x0002b;/&#x02212;</sup> or WT IL-17<sup>&#x0002b;</sup> &#x003b3;&#x003b4; T cells (<xref ref-type="fig" rid="pone-0008899-g005">Fig. 5C</xref>). Taken together, these data indicated that reducing the levels of Fyn impacts the function of &#x003b3;&#x003b4; T cells that have the potential to become either IL-17- or IFN&#x003b3;-producing effector cells, while reducing the levels of Lck only impacts the function of &#x003b3;&#x003b4; T cells that have the potential to become IFN&#x003b3;-producing effector cells.</p><p>Because Lck<sup>&#x0002b;/&#x02212;</sup> and Fyn<sup>&#x0002b;/&#x02212;</sup> &#x003b3;&#x003b4; T cells do not efficiently produce IFN&#x003b3;, it was of interest to determine whether reducing Lck or Fyn levels also affected the ability of &#x003b3;&#x003b4; T cells to produce other cytokines. To test this, we evaluated TNF&#x003b1; production by &#x003b3;&#x003b4; T cells from Lck<sup>&#x0002b;/&#x02212;</sup> &#x003b3;&#x003b4;TCR Tg and Fyn<sup>&#x0002b;/&#x02212;</sup> &#x003b3;&#x003b4;TCR Tg mice, since &#x003b3;&#x003b4; T cells, including those that produce IFN&#x003b3;, have been shown to produce this cytokine <xref ref-type="bibr" rid="pone.0008899-Ribot1">&#x0005b;40&#x0005d;</xref>. As shown in <xref ref-type="fig" rid="pone-0008899-g005">Fig. 5D</xref>, we found that more &#x003b3;&#x003b4; T cells from Lck<sup>&#x0002b;/&#x02212;</sup> &#x003b3;&#x003b4;TCR Tg and Fyn<sup>&#x0002b;/&#x02212;</sup> &#x003b3;&#x003b4;TCR Tg mice than from WT &#x003b3;&#x003b4;TCR Tg mice were producing TNF&#x003b1;. These data indicated that reducing Lck or Fyn levels does not impair the ability of &#x003b3;&#x003b4; T cells to produce TNF&#x003b1; and suggested that the TCR signals required to activate the genetic program for IFN&#x003b3; production are different than those for TNF&#x003b1; production.</p></sec></sec><sec id="s3"><title>Discussion</title><p>Since SFKs have both positive and negative roles in receptor signaling, it has been postulated that these kinases function more like rheostats than on/off switches <xref ref-type="bibr" rid="pone.0008899-Lowell1">&#x0005b;45&#x0005d;</xref>. Our data support this idea, as changes in the cellular levels of Lck or Fyn at different stages in the life of a &#x003b3;&#x003b4; lineage cell affected the strength of the &#x003b3;&#x003b4;TCR signaling response and, in turn, affected &#x003b1;&#x003b2;/&#x003b3;&#x003b4; lineage commitment, &#x003b3;&#x003b4; T cell maturation and &#x003b3;&#x003b4; T effector cell differentiation.</p><p>The expression levels of Lck and Fyn change during T cell development and maturation. Immature thymocytes (i.e., DN2 thymocytes), which have the potential to become either &#x003b1;&#x003b2; or &#x003b3;&#x003b4; lineage cells <xref ref-type="bibr" rid="pone.0008899-Petrie1">&#x0005b;26&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0008899-Ciofani1">&#x0005b;27&#x0005d;</xref>, expressed relatively high levels of both Lck and Fyn. In thymic &#x003b3;&#x003b4; lineage cells, these high levels of Lck and Fyn were maintained and, not until the &#x003b3;&#x003b4; lineage cells were exported from the thymus, did their Lck and Fyn expression levels decrease. However, in immature &#x003b1;&#x003b2; lineage cells, Lck and Fyn expression levels dramatically declined and, at the DP stage, their levels of Lck and Fyn were extremely low. The low SFK expression in DP thymocytes has also been reported by Olszowy et al. <xref ref-type="bibr" rid="pone.0008899-Olszowy1">&#x0005b;46&#x0005d;</xref>, who used quantitative Western blot analysis to measure Lck and Fyn protein levels in thymocyte subsets. Interestingly, Lck and Fyn levels were increased in TCR<sup>hi</sup> DP (data not shown) and SP thymocytes compared to DP thymocytes, suggesting that positive selection upregulated both Lck and Fyn expression. It is important to note that mature SP thymocytes, after leaving the thymus, downregulated Lck and Fyn expression levels, but not to the levels observed for DP thymocytes nor to the extent observed between thymic and peripheral &#x003b3;&#x003b4; T cells.</p><p>To investigate the importance of the quantitative difference in Lck and Fyn expression levels between thymic and peripheral &#x003b3;&#x003b4; T cells, we used Lck<sup>&#x0002b;/&#x02212;</sup> and Fyn<sup>&#x0002b;/&#x02212;</sup> mice to study the effect of reducing Lck or Fyn expression levels on &#x003b3;&#x003b4; T cell development and function. We chose to reduce, as opposed to eliminate, Lck and Fyn expression levels to prevent any compensatory action that one SFK may exhibit in the absence of the other. Although Fyn levels were reduced by 50&#x00025; in &#x003b1;&#x003b2; lineage cells from Fyn<sup>&#x0002b;/&#x02212;</sup> mice, they were only reduced by 40&#x00025; in &#x003b3;&#x003b4; lineage cells from the same mice. There are two possible explanations, which are not mutually exclusive, for why Fyn levels were not reduced to the expected 50&#x00025; in &#x003b3;&#x003b4; lineage cells from Fyn<sup>&#x0002b;/&#x02212;</sup> mice. First, the relatively high levels of Fyn in Fyn<sup>&#x0002b;/&#x02212;</sup> &#x003b3;&#x003b4; thymocytes may be a result of selection, where only cells with high levels of Fyn survive and continue to mature. The second possibility is that the high Fyn levels in &#x003b3;&#x003b4; lineage cells reflect high Fyn levels in a precursor population, such as DN2 thymocytes, which have the developmental potential to give rise to &#x003b1;&#x003b2; and &#x003b3;&#x003b4; lineage cells <xref ref-type="bibr" rid="pone.0008899-Petrie1">&#x0005b;26&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0008899-Ciofani1">&#x0005b;27&#x0005d;</xref>. Indeed, we found that Fyn expression was only reduced by &#x0223c;15&#x00025; in DN2 thymocytes from Fyn<sup>&#x0002b;/&#x02212;</sup> mice. Therefore, even though we cannot rule out selection of &#x003b3;&#x003b4; thymocytes with high levels of Fyn, it is conceivable that the relatively high levels of Fyn in &#x003b3;&#x003b4; thymocytes from Fyn<sup>&#x0002b;/&#x02212;</sup> mice may be a direct result of the high levels of Fyn in Fyn<sup>&#x0002b;/&#x02212;</sup> DN2 thymocytes.</p><p>The high level of Fyn in thymic precursors highlights the importance of Fyn activity during an early stage of T cell development. As surface TCR complexes are not expressed at this stage, it is possible that Fyn is required for signaling through other receptors. One such receptor may be the IL-7 receptor (IL-7R), as Fyn has been shown to be recruited to this receptor <xref ref-type="bibr" rid="pone.0008899-Venkitaraman1">&#x0005b;47&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0008899-Page2">&#x0005b;48&#x0005d;</xref>. Given this association and that DN2 thymocytes require IL-7R expression and signaling for their survival and proliferation <xref ref-type="bibr" rid="pone.0008899-Peschon1">&#x0005b;49&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0008899-Maraskovsky1">&#x0005b;53&#x0005d;</xref>, it is possible that relatively high levels of Fyn are required for proper IL-7R signaling at this stage.</p><p>The first stage in T cell development where we observed regulation of &#x003b3;&#x003b4;TCR signal strength by Lck and Fyn is during &#x003b1;&#x003b2;/&#x003b3;&#x003b4; lineage commitment. We and others have previously demonstrated that TCR signal strength influences the &#x003b1;&#x003b2;/&#x003b3;&#x003b4; lineage decision, with a strong signal favoring &#x003b3;&#x003b4; lineage commitment and a weak signal favoring &#x003b1;&#x003b2; lineage commitment <xref ref-type="bibr" rid="pone.0008899-Hayes1">&#x0005b;29&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0008899-Haks1">&#x0005b;33&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0008899-Kreslavsky1">&#x0005b;54&#x0005d;</xref>. By fixing the specificity of the &#x003b3;&#x003b4;TCR, we were able to detect changes in the &#x003b3;&#x003b4;TCR signal response that were not apparent with a polyclonal &#x003b3;&#x003b4;TCR repertoire. Reducing the expression of Lck weakened &#x003b3;&#x003b4;TCR signal strength and resulted in a striking increase in the percentage and number of DP thymocytes in Lck<sup>&#x0002b;/&#x02212;</sup> &#x003b3;&#x003b4;TCR Tg mice compared to WT &#x003b3;&#x003b4;TCR Tg mice. Moreover, weakening of the &#x003b3;&#x003b4;TCR signal was confirmed by the finding that DN &#x003b3;&#x003b4; thymocytes from Lck<sup>&#x0002b;/&#x02212;</sup> &#x003b3;&#x003b4;TCR Tg mice expressed higher levels of the &#x003b3;&#x003b4;TCR than WT DN &#x003b3;&#x003b4; thymocytes. Together, these results indicated that relatively high levels of Lck are required to achieve the appropriate TCR signal response to support the &#x003b3;&#x003b4; lineage choice. Conversely, reducing Fyn expression levels strengthened the &#x003b3;&#x003b4;TCR signaling response, as evidenced by the decrease, albeit not significant, in the number of DP thymocytes and the significant decrease in &#x003b3;&#x003b4;TCR surface expression on DN &#x003b3;&#x003b4; thymocytes from Fyn<sup>&#x0002b;/&#x02212;</sup> &#x003b3;&#x003b4;TCR Tg mice. In contrast to the results of our previous study, in which &#x003b3;&#x003b4; T cell fate was favored over &#x003b1;&#x003b2; T cell fate when &#x003b3;&#x003b4;TCR signal strength was augmented <xref ref-type="bibr" rid="pone.0008899-Hayes1">&#x0005b;29&#x0005d;</xref>, reducing Fyn expression had modest effects on the generation of &#x003b1;&#x003b2; and &#x003b3;&#x003b4; lineage cells. This difference may be attributed to the fact that Fyn expression was reduced by 35&#x00025; in &#x003b3;&#x003b4; thymocytes from Fyn<sup>&#x0002b;/&#x02212;</sup> &#x003b3;&#x003b4;TCR Tg mice (data not shown), suggesting that immature DN thymocytes expressing low levels of Fyn were unable to survive and develop into &#x003b1;&#x003b2; or &#x003b3;&#x003b4; lineage cells.</p><p>Our data also demonstrated that the alterations in &#x003b3;&#x003b4;TCR signal strength by reducing Lck or Fyn expression levels affected &#x003b3;&#x003b4; T cell maturation in the thymus. When &#x003b3;&#x003b4;TCR signal strength was weakened by reducing Lck levels, there was a significant decrease in the number of DN &#x003b3;&#x003b4; T cells in LNs despite normal numbers of &#x003b3;&#x003b4; lineage cells present in the thymus. In support of a maturation defect, the frequency of recent thymic emigrants (CD24<sup>&#x0002b;</sup> DN &#x003b3;&#x003b4;TCR<sup>&#x0002b;</sup>) was reduced in the LNs of Lck<sup>&#x0002b;/&#x02212;</sup> &#x003b3;&#x003b4;TCR Tg mice. Because of the reduction in thymic output, Lck<sup>&#x0002b;/&#x02212;</sup> &#x003b3;&#x003b4; T cells seemingly underwent homeostatic proliferation in the periphery, evidenced by the increased frequency of &#x003b3;&#x003b4; T cells with an activated/memory phenotype (CD44<sup>&#x0002b;</sup> DN &#x003b3;&#x003b4;TCR<sup>&#x0002b;</sup>). On the other hand, strengthening the &#x003b3;&#x003b4;TCR signal response by reducing Fyn levels had little effect on thymic maturation. These data not only demonstrate that signaling by the &#x003b3;&#x003b4;TCR is required following &#x003b3;&#x003b4; lineage commitment for &#x003b3;&#x003b4; thymocyte maturation, but also indicate that the cellular levels of Lck in &#x003b3;&#x003b4; thymocytes regulate the &#x003b3;&#x003b4;TCR signaling response at this developmental stage.</p><p>Unlike &#x003b1;&#x003b2; thymocytes, &#x003b3;&#x003b4; thymocytes do not need to encounter Ag to mature and emigrate to the periphery <xref ref-type="bibr" rid="pone.0008899-Jensen1">&#x0005b;39&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0008899-Schweighoffer1">&#x0005b;55&#x0005d;</xref>. However, a recent study demonstrates that Ag encounter in the thymus by &#x003b3;&#x003b4; T cells controls their effector fate, with Ag-experienced &#x003b3;&#x003b4; T cells expressing CD122 and preferentially producing IFN&#x003b3; and Ag-na&#x000ef;ve &#x003b3;&#x003b4; T cells lacking CD122 expression and preferentially producing IL-17 <xref ref-type="bibr" rid="pone.0008899-Jensen1">&#x0005b;39&#x0005d;</xref>. In addition to CD122 expression, &#x003b3;&#x003b4; T cell effector fate has been shown to segregate with CD27 expression, in that CD27<sup>&#x0002b;</sup> &#x003b3;&#x003b4; T cells produce IFN&#x003b3; and CD27<sup>&#x02212;</sup> &#x003b3;&#x003b4; T cells produce IL-17 <xref ref-type="bibr" rid="pone.0008899-Ribot1">&#x0005b;40&#x0005d;</xref>. We found that either weakening or augmenting the &#x003b3;&#x003b4;TCR signal response had an impact on the generation and/or survival of CD122<sup>&#x0002b;</sup> CD27<sup>&#x0002b;</sup> &#x003b3;&#x003b4; T cells but not on the generation and/or survival of CD122<sup>&#x02212;</sup> CD27<sup>&#x0002b;</sup> &#x003b3;&#x003b4; T cells. Unfortunately, we do not know whether the defect lies in CD122<sup>&#x0002b;</sup> &#x003b3;&#x003b4; T cell selection, survival or both, as very few (&#x0003c;0.5&#x00025;) CD122<sup>&#x0002b;</sup> &#x003b3;&#x003b4; T cells are detected in the thymus of WT &#x003b3;&#x003b4;TCR Tg, Lck<sup>&#x0002b;/&#x02212;</sup> &#x003b3;&#x003b4;TCR Tg, and Fyn<sup>&#x0002b;/&#x02212;</sup> &#x003b3;&#x003b4;TCR Tg mice (data not shown). Since V&#x003b3;6/V&#x003b4;1<sup>&#x0002b;</sup> &#x003b3;&#x003b4; T cells are normally generated in the fetal thymus <xref ref-type="bibr" rid="pone.0008899-Sim1">&#x0005b;28&#x0005d;</xref>, the paucity of CD122<sup>&#x0002b;</sup> &#x003b3;&#x003b4; thymocytes in WT &#x003b3;&#x003b4;TCR Tg mice may be due to decreased or negligible expression of the ligand for the V&#x003b3;6/V&#x003b4;1 &#x003b3;&#x003b4;TCR in the adult thymus. Nonetheless, we propose that weakening the &#x003b3;&#x003b4;TCR signal results in the generation of fewer CD122&#x0002b; &#x003b3;&#x003b4; thymocytes following Ag encounter in the thymus. However, due to homeostatic proliferation in the periphery, the size of the CD122<sup>&#x0002b;</sup> &#x003b3;&#x003b4; T cell pool is consequently increased. When the &#x003b3;&#x003b4;TCR signal is augmented, on the other hand, Ag encounter in the thymus may lead to negative selection and, in turn, fewer &#x003b3;&#x003b4; thymocytes and peripheral &#x003b3;&#x003b4; T cells expressing CD122. Surprisingly, in regards to &#x003b3;&#x003b4; T cells with the potential to produce IL-17, we found that neither weakening nor augmenting &#x003b3;&#x003b4;TCR signal strength had an impact on their generation and/or survival, based on the comparable expression of <italic>IL23R</italic> and <italic>IL12RB1</italic> in &#x003b3;&#x003b4; T cells from the three genotypes. These results indicate that &#x003b3;&#x003b4; T cells destined to become IL-17 producers, unlike those destined to become IFN&#x003b3; producers, are not dependent on Lck- or Fyn-mediated signaling for their generation and/or survival, and suggest that the choice to become an IFN&#x003b3; effector versus an IL-17 effector is not a binary fate decision.</p><p>Consistent with their being multiple &#x003b3;&#x003b4; effector fates is our finding that, following TCR stimulation, 10&#x00025; of WT &#x003b3;&#x003b4; T cells produce IFN&#x003b3;, 5&#x00025; produce IL-17 and 30&#x00025; produce TNF&#x003b1; &#x0005b;a third of these also produce IFN&#x003b3;, while none produce IL-17 (data not shown)&#x0005d;. Interestingly, the frequency of CD122<sup>&#x0002b;</sup> &#x003b3;&#x003b4; T cells but not CD27<sup>&#x0002b;</sup> &#x003b3;&#x003b4; T cells was found to be an indicator of IFN&#x003b3; production by &#x003b3;&#x003b4; T cells, regardless of whether the stimulated &#x003b3;&#x003b4; T cells were from WT &#x003b3;&#x003b4;TCR Tg, Lck<sup>&#x0002b;/&#x02212;</sup> &#x003b3;&#x003b4;TCR Tg, and Fyn<sup>&#x0002b;/&#x02212;</sup> &#x003b3;&#x003b4;TCR Tg mice. While our finding is consistent with the findings of the recent study demonstrating that CD122 expression correlates with IFN&#x003b3; production, it is not consistent with those of the other study demonstrating that CD27 expression correlates with IFN&#x003b3; production. An explanation for the difference in results may be how, in each study, &#x003b3;&#x003b4; T cells were stimulated. In our study, as well as that of Jensen et al. <xref ref-type="bibr" rid="pone.0008899-Goldrath1">&#x0005b;38&#x0005d;</xref>, &#x003b3;&#x003b4; T cells were stimulated by crosslinking the TCR with anti-CD3 or anti-TCR&#x003b4; mAbs. However, in the study of Ribot et al. <xref ref-type="bibr" rid="pone.0008899-Jensen1">&#x0005b;39&#x0005d;</xref>, &#x003b3;&#x003b4; T cells were first activated and expanded in the presence of anti-CD3 mAb and IL-2 for four days prior to re-stimulation with the phorbol ester, phorbol 12-myristate 13-acetate, and ionomycin. These data, taken together, suggest that CD122<sup>&#x0002b;</sup> &#x003b3;&#x003b4; T cells rapidly produce IFN&#x003b3; following TCR activation, whereas CD27<sup>&#x0002b;</sup> &#x003b3;&#x003b4; T cells require multiple days post TCR activation to differentiate into IFN&#x003b3;-producing cells. Notably, both weakening and augmenting &#x003b3;&#x003b4;TCR signal strength affected the proficiency by which &#x003b3;&#x003b4; T cells produced IFN&#x003b3; but not TNF&#x003b1;. This finding indicates that &#x003b3;&#x003b4;TCR signal strength regulates the quality of the cytokine effector response of stimulated &#x003b3;&#x003b4; T cells. Moreover, having both weak and strong TCR signals leading to a similar outcome is not novel in T cell biology, as for example it well known that DP thymocytes that receive TCR signals that are too weak or too strong undergo apoptosis &#x0005b;reviewed in 56&#x0005d;.</p><p>In summary, we have demonstrated that the cellular levels of Lck or Fyn regulate the strength of the &#x003b3;&#x003b4;TCR signaling response. Specifically, we found that reducing Lck levels, thereby weakening &#x003b3;&#x003b4;TCR signal strength, had profound effects on &#x003b1;&#x003b2;/&#x003b3;&#x003b4; lineage commitment, &#x003b3;&#x003b4; thymocyte maturation, and the generation of IFN&#x003b3;-producing effectors. In contrast, when Fyn levels were reduced, thus augmenting &#x003b3;&#x003b4;TCR signal strength, we observed defects in the generation of both IL-17- and IFN&#x003b3;-producing effectors. Thus, this study has revealed that a relatively strong &#x003b3;&#x003b4;TCR signaling response is required following &#x003b3;&#x003b4; lineage commitment for &#x003b3;&#x003b4; T cell maturation and &#x003b3;&#x003b4; T effector cell differentiation.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and Methods</title><sec id="s4a"><title>Ethics Statement</title><p>All research involving animals has been conducted according to the relevant national and international guidelines with respect to husbandry, experimentation and welfare. Mouse protocols were approved by the SUNY Upstate Medical University Committee on the Humane Use of Animals.</p></sec><sec id="s4b"><title>Mice</title><p>C57BL/6 (wild-type or WT), B6.129S2-<italic>Lck<sup>tm1Mak</sup></italic>/J (Lck<sup>&#x02212;/&#x02212;</sup>) and B6.129S7-<italic>Fyn<sup>tm1Sor</sup></italic>/J (Fyn<sup>&#x02212;/&#x02212;</sup>) mice were originally purchased from The Jackson Laboratory (Bar Harbor, ME, USA). C57BL/6-V&#x003b3;6/V&#x003b4;1 &#x003b3;&#x003b4;TCR Tg mice (&#x003b3;&#x003b4;TCR Tg; line 134) <xref ref-type="bibr" rid="pone.0008899-Sim1">&#x0005b;28&#x0005d;</xref> were kindly provided by P.E. Love (NICHD, Bethesda, MD, USA). Mice used in this study were bred and maintained in the Department of Laboratory Animal Resources at SUNY Upstate Medical University in accordance with the specifications of the Association for Assessment and Accreditation of Laboratory Animal Care. All mice were sacrificed at 6&#x02013;8 weeks of age.</p></sec><sec id="s4c"><title>Antibodies</title><p>Monoclonal antibodies (mAbs) used for flow cytometric analysis, &#x003b3;&#x003b4; T cell separation and &#x003b3;&#x003b4; T cell stimulation included anti-CD3 (145-2C11), anti-CD4 (RM4-5), anti-CD5 (53-7.3), anti-CD8&#x003b1; (53-6.7), anti-CD8&#x003b2; (53-5.8), anti-TCR&#x003b3;&#x003b4; (UC7-13D5), anti-TCR&#x003b2; (H57-597), anti-CD11b (M1/70), anti-CD16/CD32 (2.4G2), anti-CD19 (6D5), anti-IA<sup>b</sup> (AF6-120.1), anti-CD24 (M1/69), anti-CD27 (LG.7F9), anti-CD44 (IM7), anti-CD122 (5H4), anti-NK1.1 (PK136), and anti-Ly6-G/Ly6-C (RB6-8C5), which were purchased from BD Pharmingen (San Jose, CA, USA), BioLegend (San Diego, CA, USA) or eBioscience (San Diego, CA, USA). mAbs used for intracellular (i.c.) flow cytometric analysis were Ki-67 (B56; BD Pharmingen), anti-Lck (3A5; Upstate Biotechnology, Billerica, MA, USA), anti-Fyn (FYN-59; BioLegend), anti-mouse IgG<sub>2b</sub> (R12-3; BD Pharmingen), anti-IL-17A (TC11-18H10.1; BioLegend), anti-TNF&#x003b1; (MP6-XT22; BioLegend), and anti-IFN&#x003b3; (XMG1.2; BD Pharmingen).</p></sec><sec id="s4d"><title><italic>In Vitro</italic> Stimulation of &#x003b3;&#x003b4; T Cells</title><p>3&#x000d7;10<sup>6</sup> lymph node (LN) cells from WT, Lck<sup>&#x0002b;/&#x02212;</sup> and Fyn<sup>&#x0002b;/&#x02212;</sup> &#x003b3;&#x003b4;TCR Tg mice were resuspended in RPMI 1640 supplemented with non-essential amino acids, L-glutamine, HEPES, sodium pyruvate, and penicillin/streptomycin (all from Invitrogen, Carlsbad, CA, USA) in addition to 10&#x00025; FBS (Mediatech, Inc., Manassas, VA, USA), plated onto 1 or 5 &#x000b5;g/ml of immobilized anti-CD3 mAb or 5 &#x000b5;g/ml of immobilized hamster isotype control, and then cultured for 16 or 48 h at 37&#x000b0;C. 5 h prior to fixation, permeabilization, and i.c. staining with mAbs against IL-17A, TNF&#x003b1; and/or IFN&#x003b3;, cells were treated with Brefeldin A and Monensin (eBioscience).</p></sec><sec id="s4e"><title>Flow Cytometry</title><p>Flow cytometric analysis for surface antigens was performed by pre-incubating cells with the anti-CD16/CD32 mAb for at least 10 min to block non-specific binding of immunoglobulins to Fc receptors followed by staining with fluorochrome-conjugated Abs against the various surface antigens. I.c. staining for Ki-67 was performed according to the manufacturer's instructions (BD Pharmingen). I.c. staining for Lck and Fyn in addition to IL-17A, TNF&#x003b1; and IFN&#x003b3; was performed by first fixing cells in a final concentration of 1.5&#x00025; formaldehyde for 10 min at 37&#x000b0;C. Fixed cells were then stained for surface antigens, permeabilized with Perm/Wash Buffer (BD Pharmingen) for 20 min at 4&#x000b0;C, and then stained with mAbs against the appropriate proteins. The mAbs specific for IL-17A, TNF&#x003b1; and IFN&#x003b3; were directly conjugated to a fluorochrome, while FITC-conjugated anti-mouse IgG<sub>2b</sub> Ab was used as a secondary reagent to detect the anti-Lck mAb or the anti-Fyn mAb. For all experiments, 0.1&#x02013;2&#x000d7;10<sup>6</sup> cells were collected on a LSR II using FACSDiva software (BD Immunocytometry Systems, San Jose, CA, USA) and analyzed using FlowJo software (Tree Star Inc., Ashland, OR, USA). Dead cells were excluded from analysis based on forward and side scatter profiles.</p></sec><sec id="s4f"><title>Cell Separation</title><p>DN &#x003b3;&#x003b4; T cells were purified by negative selection from the LNs of WT &#x003b3;&#x003b4;TCR Tg, Lck<sup>&#x0002b;/&#x02212;</sup> &#x003b3;&#x003b4;TCR Tg and Fyn<sup>&#x0002b;/&#x02212;</sup> &#x003b3;&#x003b4;TCR Tg mice using the MACS magnetic bead separation system (Miltenyi Biotec, Auburn, CA, USA). LN cells were stained for 10 min at 4&#x000b0;C with a panel of FITC-labeled mAbs containing anti-CD19, anti-TCR&#x003b2;, anti-CD4, anti-CD8, anti-IA<sup>b</sup> and anti-DX5 mAbs. Cells were washed, incubated with anti-FITC MACS beads for 15 min at 4&#x000b0;C, and then separated on an autoMACS cell separator, according to manufacturer's directions. The purity of the resulting DN &#x003b3;&#x003b4; T cell populations were typically &#x02265;99&#x00025;.</p></sec><sec id="s4g"><title>RT-PCR Analysis</title><p>RNA was extracted from purified DN &#x003b3;&#x003b4; T cells using the Qiagen RNeasy kit (Valencia, CA, USA). cDNA was then synthesized using Invitrogen's SuperScript&#x000ae; First-Strand Synthesis System. Quantitative real-time RT-PCR analysis was performed using a Bio-Rad iQ&#x02122;5 Real-time PCR machine (Hercules, CA, USA) according to manufacturer's directions. All of the primer sets for the quantitative real-time RT-PCR analysis, which included <italic>GAPDH</italic>, <italic>IL12RB1</italic>, and <italic>IL23R</italic>, along with the SYBR Green PCR Master Mix were purchased from SABiosciences (Frederick, MD, USA).</p></sec><sec id="s4h"><title>Statistical Analysis</title><p>Data are presented as mean &#x000b1; SEM. Student's t-test was used for all statistical comparisons (Graph Pad Prism or Microsoft Excel software) except for the one evaluating Fyn levels in &#x003b1;&#x003b2; lineage cells, &#x003b3;&#x003b4; lineage cells and DN2 thymocytes from Fyn<sup>&#x0002b;/&#x02212;</sup> mice, in which a &#x003c7;<sup>2</sup> test (Microsoft Excel software) was used. <italic>p</italic> values less than or equal to 0.05 were considered statistically significant.</p></sec></sec></body><back><ack><p>We thank Teresa de Veyra and Alyse Douglass for excellent technical assistance. We also thank Drs. Karen Laky and Paul Love for helpful advice and critical review of the manuscript.</p></ack><ref-list><title>References</title><ref id="pone.0008899-Palacios1"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Palacios</surname><given-names>EH</given-names></name><name><surname>Weiss</surname><given-names>A</given-names></name></person-group><year>2004</year><article-title>Function of the Src-family kinases, Lck and Fyn, in T-cell development and activation.</article-title><source>Oncogene</source><volume>23</volume><fpage>7990</fpage><lpage>8000</lpage><pub-id pub-id-type="pmid">15489916</pub-id></mixed-citation></ref><ref id="pone.0008899-Salmond1"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salmond</surname><given-names>RJ</given-names></name><name><surname>Filby</surname><given-names>A</given-names></name><name><surname>Qureshi</surname><given-names>I</given-names></name><name><surname>Caserta</surname><given-names>S</given-names></name><name><surname>Zamoyska</surname><given-names>R</given-names></name></person-group><year>2009</year><article-title>T-cell receptor proximal signaling via the Src-family kinases, Lck and Fyn, influences T-cell activation, differentiation, and tolerance.</article-title><source>Immunol Rev</source><volume>228</volume><fpage>9</fpage><lpage>22</lpage><pub-id pub-id-type="pmid">19290918</pub-id></mixed-citation></ref><ref id="pone.0008899-Appleby1"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Appleby</surname><given-names>MW</given-names></name><name><surname>Gross</surname><given-names>JA</given-names></name><name><surname>Cooke</surname><given-names>MP</given-names></name><name><surname>Levin</surname><given-names>SD</given-names></name><name><surname>Qian</surname><given-names>X</given-names></name><etal/></person-group><year>1992</year><article-title>Defective T cell receptor signaling in mice lacking the thymic isoform of p59fyn.</article-title><source>Cell</source><volume>70</volume><fpage>751</fpage><lpage>763</lpage><pub-id pub-id-type="pmid">1516132</pub-id></mixed-citation></ref><ref id="pone.0008899-Straus1"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Straus</surname><given-names>DB</given-names></name><name><surname>Weiss</surname><given-names>A</given-names></name></person-group><year>1992</year><article-title>Genetic evidence for the involvement of the lck tyrosine kinase in signal transduction through the T cell antigen receptor.</article-title><source>Cell</source><volume>70</volume><fpage>585</fpage><lpage>593</lpage><pub-id pub-id-type="pmid">1505025</pub-id></mixed-citation></ref><ref id="pone.0008899-Stein1"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stein</surname><given-names>PL</given-names></name><name><surname>Lee</surname><given-names>HM</given-names></name><name><surname>Rich</surname><given-names>S</given-names></name><name><surname>Soriano</surname><given-names>S</given-names></name></person-group><year>1992</year><article-title>pp59fyn mutant mice display differential signaling in thymocytes and peripheral T cells.</article-title><source>Cell</source><volume>70</volume><fpage>741</fpage><lpage>750</lpage><pub-id pub-id-type="pmid">1387588</pub-id></mixed-citation></ref><ref id="pone.0008899-vanOers1"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Oers</surname><given-names>NS</given-names></name><name><surname>Killeen</surname><given-names>N</given-names></name><name><surname>Weiss</surname><given-names>A</given-names></name></person-group><year>1996</year><article-title>Lck regulates the tyrosine phosphorylation of the T cell receptor subunits and ZAP-70 in murine thymocytes.</article-title><source>J Exp Me</source><volume>183</volume><fpage>1053</fpage><lpage>1062</lpage></mixed-citation></ref><ref id="pone.0008899-Utting1"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Utting</surname><given-names>O</given-names></name><name><surname>Teh</surname><given-names>SJ</given-names></name><name><surname>Teh</surname><given-names>HS</given-names></name></person-group><year>1998</year><article-title>T cells expressing receptors of different affinity for antigen ligands reveal a unique role for p59fyn in T cell development and optimal stimulation of T cells by antigen.</article-title><source>J Immuno</source><volume>160</volume><fpage>5410</fpage><lpage>5419</lpage></mixed-citation></ref><ref id="pone.0008899-Denny1"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Denny</surname><given-names>MF</given-names></name><name><surname>Patai</surname><given-names>B</given-names></name><name><surname>Straus</surname><given-names>DB</given-names></name></person-group><year>2000</year><article-title>Differential T-cell antigen receptor signaling mediated by the Src family kinases Lck and Fyn.</article-title><source>Mol Cell Bio</source><volume>20</volume><fpage>1426</fpage><lpage>1435</lpage><pub-id pub-id-type="pmid">10648627</pub-id></mixed-citation></ref><ref id="pone.0008899-Trobridge1"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trobridge</surname><given-names>PA</given-names></name><name><surname>Levin</surname><given-names>SD</given-names></name></person-group><year>2001</year><article-title>Lck plays a critical role in Ca(2&#x0002b;) mobilization and CD28 costimulation in mature primary T cells.</article-title><source>Eur J Immunol</source><volume>31</volume><fpage>3567</fpage><lpage>3579</lpage><pub-id pub-id-type="pmid">11745376</pub-id></mixed-citation></ref><ref id="pone.0008899-Ley1"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ley</surname><given-names>SC</given-names></name><name><surname>Marsh</surname><given-names>M</given-names></name><name><surname>Bebbington</surname><given-names>CR</given-names></name><name><surname>Proudfoot</surname><given-names>K</given-names></name><name><surname>Jordan</surname><given-names>P</given-names></name></person-group><year>1994</year><article-title>Distinct intracellular localization of Lck and Fyn protein tyrosine kinases in human T lymphocytes.</article-title><source>J Cell Biol</source><volume>125</volume><fpage>639</fpage><lpage>649</lpage><pub-id pub-id-type="pmid">7513706</pub-id></mixed-citation></ref><ref id="pone.0008899-Yasuda1"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yasuda</surname><given-names>K</given-names></name><name><surname>Nagafuku</surname><given-names>M</given-names></name><name><surname>Shima</surname><given-names>T</given-names></name><name><surname>Okada</surname><given-names>M</given-names></name><name><surname>Yagi</surname><given-names>T</given-names></name><etal/></person-group><year>2002</year><article-title>Cutting Edge: Fyn is essential for tyrosine phosphorylation of Csk-binding protein/Phosphoprotein associated with glycolipid-enriched microdomains in lipid rafts in resting T cells.</article-title><source>J Immuno</source><volume>169</volume><fpage>2813</fpage><lpage>2817</lpage></mixed-citation></ref><ref id="pone.0008899-Zamoyska1"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zamoyska</surname><given-names>R</given-names></name><name><surname>Basson</surname><given-names>A</given-names></name><name><surname>Filby</surname><given-names>A</given-names></name><name><surname>Legname</surname><given-names>G</given-names></name><name><surname>Lovatt</surname><given-names>M</given-names></name><etal/></person-group><year>2003</year><article-title>The influence of the src-family kinases, lck and fyn, on T cell differentiation, survival and activation.</article-title><source>Immunol Rev</source><volume>191</volume><fpage>107</fpage><lpage>118</lpage><pub-id pub-id-type="pmid">12614355</pub-id></mixed-citation></ref><ref id="pone.0008899-Molina1"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Molina</surname><given-names>TJ</given-names></name><name><surname>Kishihara</surname><given-names>K</given-names></name><name><surname>Siderovski</surname><given-names>DP</given-names></name><name><surname>van Ewijk</surname><given-names>W</given-names></name><name><surname>Narendran</surname><given-names>A</given-names></name><etal/></person-group><year>1992</year><article-title>Profound block in thymocyte development in mice lacking p56<sup>lck</sup>.</article-title><source>Nature</source><volume>357</volume><fpage>161</fpage><lpage>164</lpage><pub-id pub-id-type="pmid">1579166</pub-id></mixed-citation></ref><ref id="pone.0008899-Groves1"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Groves</surname><given-names>T</given-names></name><name><surname>Smiley</surname><given-names>P</given-names></name><name><surname>Cooke</surname><given-names>MP</given-names></name><name><surname>Forbush</surname><given-names>K</given-names></name><name><surname>Perlmutter</surname><given-names>RM</given-names></name><etal/></person-group><year>1996</year><article-title>Fyn can partially substitute for Lck in T lymphocyte development.</article-title><source>Immunity</source><volume>5</volume><fpage>417</fpage><lpage>428</lpage><pub-id pub-id-type="pmid">8934569</pub-id></mixed-citation></ref><ref id="pone.0008899-Legname1"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Legname</surname><given-names>G</given-names></name><name><surname>Seddon</surname><given-names>B</given-names></name><name><surname>Lovatt</surname><given-names>M</given-names></name><name><surname>Tomlinson</surname><given-names>P</given-names></name><name><surname>Sarner</surname><given-names>N</given-names></name><etal/></person-group><year>2002</year><article-title>Inducible expression of a p56<sup>Lck</sup> transgene reveals a central role for Lck in the differentiation of CD4 SP thymocytes.</article-title><source>Immunity</source><volume>12</volume><fpage>537</fpage><lpage>46</lpage><pub-id pub-id-type="pmid">10843386</pub-id></mixed-citation></ref><ref id="pone.0008899-Lovatt1"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lovatt</surname><given-names>M</given-names></name><name><surname>Filby</surname><given-names>A</given-names></name><name><surname>Parravicini</surname><given-names>V</given-names></name><name><surname>Werlen</surname><given-names>G</given-names></name><name><surname>Palmer</surname><given-names>E</given-names></name><etal/></person-group><year>2006</year><article-title>Lck regulates the threshold of activation in primary T cells, while both Lck and Fyn contribute to the magnitude of the extracellular signal-related kinase response.</article-title><source>Mol Cell Biol</source><volume>26</volume><fpage>8655</fpage><lpage>65</lpage><pub-id pub-id-type="pmid">16966372</pub-id></mixed-citation></ref><ref id="pone.0008899-Seddon1"><label>17</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seddon</surname><given-names>B</given-names></name><name><surname>Legname</surname><given-names>G</given-names></name><name><surname>Tomlinson</surname><given-names>P</given-names></name><name><surname>Zamoyska</surname><given-names>R</given-names></name></person-group><year>2000</year><article-title>Long-term survival but impaired homeostatic proliferation of naive T cells in the absence of p56<sup>lck</sup>.</article-title><source>Science</source><volume>290</volume><fpage>127</fpage><lpage>131</lpage><pub-id pub-id-type="pmid">11021796</pub-id></mixed-citation></ref><ref id="pone.0008899-Brdicka1"><label>18</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brdicka</surname><given-names>T</given-names></name><name><surname>Pavlistova</surname><given-names>D</given-names></name><name><surname>Leo</surname><given-names>A</given-names></name><name><surname>Bruyns</surname><given-names>E</given-names></name><name><surname>Korinek</surname><given-names>V</given-names></name><etal/></person-group><article-title>Phosphoprotein associated with glycosphingolipid-enriched microdomains (PAG), a novel ubiquitously expressed transmembrane adaptor protein, binds the protein tyrosine kinase Csk and is involved in regulation of T cell activation.</article-title><source>J Exp Med</source><volume>191</volume><fpage>1591</fpage><lpage>1599</lpage><pub-id pub-id-type="pmid">10790433</pub-id></mixed-citation></ref><ref id="pone.0008899-Filby1"><label>19</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Filby</surname><given-names>A</given-names></name><name><surname>Seddon</surname><given-names>B</given-names></name><name><surname>Kleczkowska</surname><given-names>J</given-names></name><name><surname>Salmond</surname><given-names>R</given-names></name><name><surname>Tomlinson</surname><given-names>P</given-names></name><etal/></person-group><year>2007</year><article-title>Fyn regulates the duration of TCR engagement needed for commitment to effector function.</article-title><source>J Immunol</source><volume>179</volume><fpage>4635</fpage><lpage>4644</lpage><pub-id pub-id-type="pmid">17878361</pub-id></mixed-citation></ref><ref id="pone.0008899-Mamchak1"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mamchak</surname><given-names>AA</given-names></name><name><surname>Sullivan</surname><given-names>BM</given-names></name><name><surname>Hou</surname><given-names>B</given-names></name><name><surname>Lee</surname><given-names>LM</given-names></name><name><surname>Gilden</surname><given-names>JK</given-names></name><etal/></person-group><year>2008</year><article-title>Normal development and activation but altered cytokine production of Fyn-deficient CD4<sup>&#x0002b;</sup> T cells.</article-title><source>J Immunol</source><volume>181</volume><fpage>5374</fpage><lpage>85</lpage><pub-id pub-id-type="pmid">18832694</pub-id></mixed-citation></ref><ref id="pone.0008899-vanOers2"><label>21</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Oers</surname><given-names>NS</given-names></name><name><surname>Lowin-Kropf</surname><given-names>B</given-names></name><name><surname>Finlay</surname><given-names>D</given-names></name><name><surname>Connolly</surname><given-names>K</given-names></name><name><surname>Weiss</surname><given-names>A</given-names></name></person-group><year>1996</year><article-title>&#x003b1;&#x003b2; T cell development is abolished in mice lacking both Lck and Fyn protein tyrosine kinases.</article-title><source>Immunity</source><volume>5</volume><fpage>429</fpage><lpage>436</lpage><pub-id pub-id-type="pmid">8934570</pub-id></mixed-citation></ref><ref id="pone.0008899-Page1"><label>22</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Page</surname><given-names>ST</given-names></name><name><surname>van Oers</surname><given-names>NS</given-names></name><name><surname>Perlmutter</surname><given-names>RM</given-names></name><name><surname>Weiss</surname><given-names>A</given-names></name><name><surname>Pullen</surname><given-names>AM</given-names></name></person-group><year>1997</year><article-title>Differential contribution of Lck and Fyn protein tyrosine kinases to intraepithelial lymphocyte development.</article-title><source>Eur J Immunol</source><volume>27</volume><fpage>554</fpage><lpage>562</lpage><pub-id pub-id-type="pmid">9045930</pub-id></mixed-citation></ref><ref id="pone.0008899-Penninger1"><label>23</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Penninger</surname><given-names>J</given-names></name><name><surname>Kishihara</surname><given-names>K</given-names></name><name><surname>Molina</surname><given-names>T</given-names></name><name><surname>Wallace</surname><given-names>VA</given-names></name><name><surname>Timms</surname><given-names>E</given-names></name><etal/></person-group><year>1993</year><article-title>Requirement for tyrosine kinase p56lck for thymic development of transgenic &#x003b3;&#x003b4; T cells.</article-title><source>Science</source><volume>260</volume><fpage>358</fpage><lpage>361</lpage><pub-id pub-id-type="pmid">8469988</pub-id></mixed-citation></ref><ref id="pone.0008899-Kawai1"><label>24</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawai</surname><given-names>K</given-names></name><name><surname>Kishihara</surname><given-names>K</given-names></name><name><surname>Molina</surname><given-names>TJ</given-names></name><name><surname>Wallace</surname><given-names>VA</given-names></name><name><surname>Mak</surname><given-names>TW</given-names></name><etal/></person-group><year>1995</year><article-title>Impaired development of V&#x003b3;3 dendritic epidermal T cells in p56<sup>lck</sup> protein tyrosine kinase-deficient and CD45 protein tyrosine phosphatase-deficient mice.</article-title><source>J Exp Med</source><volume>181</volume><fpage>345</fpage><lpage>349</lpage><pub-id pub-id-type="pmid">7807014</pub-id></mixed-citation></ref><ref id="pone.0008899-Buckland1"><label>25</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buckland</surname><given-names>J</given-names></name><name><surname>Pennington</surname><given-names>DJ</given-names></name><name><surname>Bruno</surname><given-names>L</given-names></name><name><surname>Owen</surname><given-names>MJ</given-names></name></person-group><year>2000</year><article-title>Co-ordination of the expression of the protein tyrosine kinase p56(lck) with the pre-T cell receptor during thymocyte development.</article-title><source>Eur J Immunol</source><volume>30</volume><fpage>8</fpage><lpage>18</lpage><pub-id pub-id-type="pmid">10602022</pub-id></mixed-citation></ref><ref id="pone.0008899-Petrie1"><label>26</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petrie</surname><given-names>HT</given-names></name><name><surname>Scollay</surname><given-names>R</given-names></name><name><surname>Shortman</surname><given-names>K</given-names></name></person-group><year>1992</year><article-title>Commitment to the T cell receptor-&#x003b1;&#x003b2; or -&#x003b3;&#x003b4; lineages can occur just prior to the onset of CD4 and CD8 expression among immature thymocytes.</article-title><source>Eur J Immunol</source><volume>22</volume><fpage>2185</fpage><lpage>2188</lpage><pub-id pub-id-type="pmid">1386319</pub-id></mixed-citation></ref><ref id="pone.0008899-Ciofani1"><label>27</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ciofani</surname><given-names>M</given-names></name><name><surname>Knowles</surname><given-names>GC</given-names></name><name><surname>Wiest</surname><given-names>DL</given-names></name><name><surname>von Boehmer</surname><given-names>H</given-names></name><name><surname>Zuniga-Pflucker</surname><given-names>JC</given-names></name></person-group><year>2006</year><article-title>Stage-specific and differential notch dependency at the &#x003b1;&#x003b2; and &#x003b3;&#x003b4; T lineage bifurcation.</article-title><source>Immunity</source><volume>25</volume><fpage>105</fpage><lpage>116</lpage><pub-id pub-id-type="pmid">16814577</pub-id></mixed-citation></ref><ref id="pone.0008899-Sim1"><label>28</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sim</surname><given-names>GK</given-names></name><name><surname>Olsson</surname><given-names>C</given-names></name><name><surname>Augustin</surname><given-names>A</given-names></name></person-group><year>1995</year><article-title>Commitment and maintenance of the &#x003b1;&#x003b2; and &#x003b3;&#x003b4; T cell lineages.</article-title><source>J Immunol</source><volume>154</volume><fpage>5821</fpage><lpage>31</lpage><pub-id pub-id-type="pmid">7751631</pub-id></mixed-citation></ref><ref id="pone.0008899-Hayes1"><label>29</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hayes</surname><given-names>SM</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Love</surname><given-names>PE</given-names></name></person-group><year>2005</year><article-title>TCR signal strength influences &#x003b1;&#x003b2;/&#x003b3;&#x003b4; lineage fate.</article-title><source>Immunity</source><volume>22</volume><fpage>583</fpage><lpage>593</lpage><pub-id pub-id-type="pmid">15894276</pub-id></mixed-citation></ref><ref id="pone.0008899-Hayes2"><label>30</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hayes</surname><given-names>SM</given-names></name><name><surname>Love</surname><given-names>PE</given-names></name></person-group><year>2002</year><article-title>Distinct structure and signaling potential of the &#x003b3;&#x003b4;TCR complex.</article-title><source>Immunity</source><volume>16</volume><fpage>827</fpage><lpage>38</lpage><pub-id pub-id-type="pmid">12121664</pub-id></mixed-citation></ref><ref id="pone.0008899-Laird1"><label>31</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laird</surname><given-names>RM</given-names></name><name><surname>Hayes</surname><given-names>SM</given-names></name></person-group><year>2009</year><article-title>Profiling of the early transcriptional response of murine &#x003b3;&#x003b4; T cells following TCR stimulation.</article-title><source>Mol Immunol</source><volume>46</volume><fpage>2429</fpage><lpage>2438</lpage><pub-id pub-id-type="pmid">19439358</pub-id></mixed-citation></ref><ref id="pone.0008899-Pennington1"><label>32</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pennington</surname><given-names>DJ</given-names></name><name><surname>Silva-Santos</surname><given-names>B</given-names></name><name><surname>Shires</surname><given-names>J</given-names></name><name><surname>Theodoridis</surname><given-names>E</given-names></name><name><surname>Pollitt</surname><given-names>C</given-names></name><etal/></person-group><year>2003</year><article-title>The inter-relatedness and interdependence of mouse T cell receptor &#x003b3;&#x003b4;<sup>&#x0002b;</sup> and &#x003b1;&#x003b2;<sup>&#x0002b;</sup> cells.</article-title><source>Nat Immunol</source><volume>4</volume><fpage>991</fpage><lpage>998</lpage><pub-id pub-id-type="pmid">14502287</pub-id></mixed-citation></ref><ref id="pone.0008899-Haks1"><label>33</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haks</surname><given-names>MC</given-names></name><name><surname>Lefebvre</surname><given-names>JM</given-names></name><name><surname>Lauritsen</surname><given-names>JP</given-names></name><name><surname>Carleton</surname><given-names>M</given-names></name><name><surname>Rhodes</surname><given-names>M</given-names></name><etal/></person-group><year>2005</year><article-title>Attenuation of &#x003b3;&#x003b4;TCR signaling efficiently diverts thymocytes to the &#x003b1;&#x003b2; lineage.</article-title><source>Immunity</source><volume>22</volume><fpage>595</fpage><lpage>606</lpage><pub-id pub-id-type="pmid">15894277</pub-id></mixed-citation></ref><ref id="pone.0008899-Gerdes1"><label>34</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gerdes</surname><given-names>J</given-names></name><name><surname>Lemke</surname><given-names>H</given-names></name><name><surname>Baisch</surname><given-names>H</given-names></name><name><surname>Wacker</surname><given-names>HH</given-names></name><name><surname>Schwab</surname><given-names>U</given-names></name><etal/></person-group><year>1984</year><article-title>Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67.</article-title><source>J Immunol</source><volume>133</volume><fpage>1710</fpage><lpage>1715</lpage><pub-id pub-id-type="pmid">6206131</pub-id></mixed-citation></ref><ref id="pone.0008899-Bruno1"><label>35</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bruno</surname><given-names>S</given-names></name><name><surname>Darzynkiewicz</surname><given-names>Z</given-names></name></person-group><year>1992</year><article-title>Cell cycle dependent expression and stability of the nuclear protein detected by Ki-67 antibody in HL-60 cells.</article-title><source>Cell Prolif</source><volume>25</volume><fpage>31</fpage><lpage>40</lpage><pub-id pub-id-type="pmid">1540682</pub-id></mixed-citation></ref><ref id="pone.0008899-Tough1"><label>36</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tough</surname><given-names>DF</given-names></name><name><surname>Sprent</surname><given-names>J</given-names></name></person-group><year>1998</year><article-title>Lifespan of gamma/delta T cells.</article-title><source>J Exp Med</source><volume>187</volume><fpage>357</fpage><lpage>365</lpage><pub-id pub-id-type="pmid">9449716</pub-id></mixed-citation></ref><ref id="pone.0008899-MuraliKrishna1"><label>37</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murali-Krishna</surname><given-names>K</given-names></name><name><surname>Ahmed</surname><given-names>R</given-names></name></person-group><year>2000</year><article-title>Cutting edge: naive T cells masquerading as memory cells.</article-title><source>J Immunol</source><volume>165</volume><fpage>1733</fpage><lpage>1737</lpage><pub-id pub-id-type="pmid">10925249</pub-id></mixed-citation></ref><ref id="pone.0008899-Goldrath1"><label>38</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goldrath</surname><given-names>AW</given-names></name><name><surname>Bogatzki</surname><given-names>LY</given-names></name><name><surname>Bevan</surname><given-names>MJ</given-names></name></person-group><year>2000</year><article-title>Naive T cells transiently acquire a memory-like phenotype during homeostasis-driven proliferation.</article-title><source>J Exp Med</source><volume>192</volume><fpage>557</fpage><lpage>564</lpage><pub-id pub-id-type="pmid">10952725</pub-id></mixed-citation></ref><ref id="pone.0008899-Jensen1"><label>39</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jensen</surname><given-names>KD</given-names></name><name><surname>Su</surname><given-names>X</given-names></name><name><surname>Shin</surname><given-names>S</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Youssef</surname><given-names>S</given-names></name><etal/></person-group><year>2008</year><article-title>Thymic selection determines &#x003b3;&#x003b4; T cell effector fate: antigen-naive cells make interleukin-17 and antigen-experienced cells make interferon &#x003b3;.</article-title><source>Immunity</source><volume>29</volume><fpage>90</fpage><lpage>100</lpage><pub-id pub-id-type="pmid">18585064</pub-id></mixed-citation></ref><ref id="pone.0008899-Ribot1"><label>40</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ribot</surname><given-names>JC</given-names></name><name><surname>deBarros</surname><given-names>A</given-names></name><name><surname>Pang</surname><given-names>DJ</given-names></name><name><surname>Neves</surname><given-names>JF</given-names></name><name><surname>Peperzak</surname><given-names>V</given-names></name><etal/></person-group><year>2009</year><article-title>CD27 is a thymic determinant of the balance between interferon-&#x003b3;- and interleukin 17-producing &#x003b3;&#x003b4; T cell subsets.</article-title><source>Nat Immunol</source><volume>10</volume><fpage>427</fpage><lpage>436</lpage><pub-id pub-id-type="pmid">19270712</pub-id></mixed-citation></ref><ref id="pone.0008899-Awashi1"><label>41</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Awashi</surname><given-names>A</given-names></name><name><surname>Riol-Blanco</surname><given-names>L</given-names></name><name><surname>J&#x000e4;ger</surname><given-names>A</given-names></name><name><surname>Korn</surname><given-names>T</given-names></name><name><surname>Pot</surname><given-names>C</given-names></name><etal/></person-group><year>2009</year><article-title>Cutting edge: IL-23 receptor gfp reporter mice reveal distinct populations of IL-17 producing cells.</article-title><source>J Immunol</source><volume>182</volume><fpage>5904</fpage><lpage>5908</lpage><pub-id pub-id-type="pmid">19414740</pub-id></mixed-citation></ref><ref id="pone.0008899-Martin1"><label>42</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname><given-names>B</given-names></name><name><surname>Hirota</surname><given-names>K</given-names></name><name><surname>Cua</surname><given-names>DJ</given-names></name><name><surname>Stockinger</surname><given-names>B</given-names></name><name><surname>Veldhoen</surname><given-names>M</given-names></name></person-group><year>2009</year><article-title>Interleukin-17-producing &#x003b3;&#x003b4; T cells selectively expand in response to pathogen products and environmental signals.</article-title><source>Immunity</source><volume>31</volume><fpage>321</fpage><lpage>330</lpage><pub-id pub-id-type="pmid">19682928</pub-id></mixed-citation></ref><ref id="pone.0008899-Sutton1"><label>43</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sutton</surname><given-names>CE</given-names></name><name><surname>Lalor</surname><given-names>SJ</given-names></name><name><surname>Sweeney</surname><given-names>CM</given-names></name><name><surname>Brereton</surname><given-names>CF</given-names></name><name><surname>Lavelle</surname><given-names>EC</given-names></name><etal/></person-group><year>2009</year><article-title>Interleukin-1 and IL-23 induce innate IL-17 production from &#x003b3;&#x003b4; T cells, amplifying Th17 responses and autoimmunity.</article-title><source>Immunity</source><volume>31</volume><fpage>331</fpage><lpage>341</lpage><pub-id pub-id-type="pmid">19682929</pub-id></mixed-citation></ref><ref id="pone.0008899-Parham1"><label>44</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parham</surname><given-names>C</given-names></name><name><surname>Chirica</surname><given-names>M</given-names></name><name><surname>Timans</surname><given-names>J</given-names></name><name><surname>Vaisberg</surname><given-names>E</given-names></name><name><surname>Travis</surname><given-names>M</given-names></name><etal/></person-group><year>2002</year><article-title>A receptor for the heterodimeric cytokine IL-23 is composed of IL-12R&#x003b2;1 and a novel cytokine receptor subunit, IL-23R.</article-title><source>J Immunol</source><volume>168</volume><fpage>5699</fpage><lpage>5708</lpage><pub-id pub-id-type="pmid">12023369</pub-id></mixed-citation></ref><ref id="pone.0008899-Lowell1"><label>45</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lowell</surname><given-names>CA</given-names></name></person-group><year>2004</year><article-title>Src-family kinases: rheostats of immune cell signaling.</article-title><source>Mol Immunol</source><volume>41</volume><fpage>631</fpage><lpage>643</lpage><pub-id pub-id-type="pmid">15220000</pub-id></mixed-citation></ref><ref id="pone.0008899-Olszowy1"><label>46</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olszowy</surname><given-names>MW</given-names></name><name><surname>Leuchtmann</surname><given-names>PL</given-names></name><name><surname>Veillette</surname><given-names>A</given-names></name><name><surname>Shaw</surname><given-names>AS</given-names></name></person-group><year>1995</year><article-title>Comparison of p56lck and p59fyn protein expression in thymocyte subsets, peripheral T cells, NK cells and lymphoid cell lines.</article-title><source>J Immunol</source><volume>155</volume><fpage>4236</fpage><lpage>4240</lpage><pub-id pub-id-type="pmid">7594580</pub-id></mixed-citation></ref><ref id="pone.0008899-Venkitaraman1"><label>47</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Venkitaraman</surname><given-names>AR</given-names></name><name><surname>Cowling</surname><given-names>RJ</given-names></name></person-group><year>1992</year><article-title>Interleukin 7 receptor functions by recruiting the tyrosine kinase p59<sup>fyn</sup> through a segment of its cytoplasmic tail.</article-title><source>Proc Natl Acad Sci USA</source><volume>89</volume><fpage>12083</fpage><lpage>12087</lpage><pub-id pub-id-type="pmid">1465444</pub-id></mixed-citation></ref><ref id="pone.0008899-Page2"><label>48</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Page</surname><given-names>TH</given-names></name><name><surname>Lali</surname><given-names>FV</given-names></name><name><surname>Foxwell</surname><given-names>BM</given-names></name></person-group><year>1995</year><article-title>Interleukin-7 activates p56<sup>lck</sup> and p59<sup>fyn</sup>, two tyrosine kinases associated with the p90 interleukin-7 receptor in primary human T cells.</article-title><source>Eur J Immunol</source><volume>25</volume><fpage>2956</fpage><lpage>2960</lpage><pub-id pub-id-type="pmid">7589097</pub-id></mixed-citation></ref><ref id="pone.0008899-Peschon1"><label>49</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peschon</surname><given-names>JJ</given-names></name><name><surname>Morrissey</surname><given-names>PJ</given-names></name><name><surname>Grabstein</surname><given-names>KH</given-names></name><name><surname>Ramsdell</surname><given-names>FJ</given-names></name><name><surname>Maraskovsky</surname><given-names>E</given-names></name><etal/></person-group><year>1994</year><article-title>Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice.</article-title><source>J Exp Med</source><volume>180</volume><fpage>1955</fpage><lpage>1960</lpage><pub-id pub-id-type="pmid">7964471</pub-id></mixed-citation></ref><ref id="pone.0008899-Akashi1"><label>50</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akashi</surname><given-names>K</given-names></name><name><surname>Kondo</surname><given-names>M</given-names></name><name><surname>von Freeden-Jeffry</surname><given-names>U</given-names></name><name><surname>Murray</surname><given-names>R</given-names></name><name><surname>Weissman</surname><given-names>IL</given-names></name></person-group><year>1997</year><article-title>Bcl-2 rescues T lymphopoiesis in interleukin-7 receptor-deficient mice.</article-title><source>Cell</source><volume>89</volume><fpage>1033</fpage><lpage>1041</lpage><pub-id pub-id-type="pmid">9215626</pub-id></mixed-citation></ref><ref id="pone.0008899-vonFreedenJeffry1"><label>51</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>von Freeden-Jeffry</surname><given-names>U</given-names></name><name><surname>Solvason</surname><given-names>N</given-names></name><name><surname>Howard</surname><given-names>M</given-names></name><name><surname>Murray</surname><given-names>R</given-names></name></person-group><year>1997</year><article-title>The earliest T lineage-committed cells depend on IL-7 for Bcl-2 expression and normal cell cycle progression.</article-title><source>Immunity</source><volume>7</volume><fpage>147</fpage><lpage>154</lpage><pub-id pub-id-type="pmid">9252127</pub-id></mixed-citation></ref><ref id="pone.0008899-Kim1"><label>52</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>K</given-names></name><name><surname>Lee</surname><given-names>CK</given-names></name><name><surname>Sayers</surname><given-names>TJ</given-names></name><name><surname>Muegge</surname><given-names>K</given-names></name><name><surname>Durum</surname><given-names>SK</given-names></name></person-group><year>1998</year><article-title>The trophic action of IL-7 on pro-T cells: inhibition of apoptosis of pro-T1, -T2, and -T3 cells correlates with Bcl-2 and Bax levels and is independent of Fas and p53 pathways.</article-title><source>J Immunol</source><volume>160</volume><fpage>5735</fpage><lpage>5741</lpage><pub-id pub-id-type="pmid">9637482</pub-id></mixed-citation></ref><ref id="pone.0008899-Maraskovsky1"><label>53</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maraskovsky</surname><given-names>E</given-names></name><name><surname>O'Reilly</surname><given-names>LA</given-names></name><name><surname>Teepe</surname><given-names>M</given-names></name><name><surname>Corcoran</surname><given-names>LM</given-names></name><name><surname>Peschon</surname><given-names>JJ</given-names></name><etal/></person-group><year>1997</year><article-title>Bcl-2 can rescue T lymphocyte development in interleukin-7 receptor-deficient mice but not in mutant rag-1<sup>&#x02212;/&#x02212;</sup> mice.</article-title><source>Cell</source><volume>89</volume><fpage>1011</fpage><lpage>1019</lpage><pub-id pub-id-type="pmid">9215624</pub-id></mixed-citation></ref><ref id="pone.0008899-Kreslavsky1"><label>54</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kreslavsky</surname><given-names>T</given-names></name><name><surname>Garbe</surname><given-names>AI</given-names></name><name><surname>Krueger</surname><given-names>A</given-names></name><name><surname>von Boehmer</surname><given-names>H</given-names></name></person-group><year>2008</year><article-title>T cell receptor-instructed &#x003b1;&#x003b2; versus &#x003b3;&#x003b4; lineage commitment revealed by single-cell analysis.</article-title><source>J Exp Med</source><volume>205</volume><fpage>1173</fpage><lpage>1186</lpage><pub-id pub-id-type="pmid">18443226</pub-id></mixed-citation></ref><ref id="pone.0008899-Schweighoffer1"><label>55</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schweighoffer</surname><given-names>E</given-names></name><name><surname>Fowlkes</surname><given-names>BJ</given-names></name></person-group><year>1996</year><article-title>Positive selection is not required for thymic maturation of transgenic &#x003b3;&#x003b4; T cells.</article-title><source>J Exp Med</source><volume>183</volume><fpage>2033</fpage><lpage>2041</lpage><pub-id pub-id-type="pmid">8642314</pub-id></mixed-citation></ref><ref id="pone.0008899-Palmer1"><label>56</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Palmer</surname><given-names>E</given-names></name></person-group><year>2003</year><article-title>Negative selection&#x02013;clearing out the bad apples from the T-cell repertoire.</article-title><source>Nat Rev Immunol</source><volume>3</volume><fpage>383</fpage><lpage>391</lpage><pub-id pub-id-type="pmid">12766760</pub-id></mixed-citation></ref></ref-list><fn-group><fn fn-type="conflict"><p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p></fn><fn fn-type="financial-disclosure"><p><bold>Funding: </bold>This work was supported in part by the Hendricks Fund for Medical Research awarded to S.M.H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</p></fn></fn-group></back></article>